# Medical Question & Answer

**Sample ID**: bbce80cd-f236-6d85-9341-8835a7eeb601
**Dataset Index**: 75290

---

## Question

What is the ICD-10 code for muscle-eye-brain disease?

---

## Answer

> Let's see… What do we have here? The user is asking for the ICD-10 code for muscle-eye-brain disease. Let's break this down step-by-step. First, I need to think about what muscle-eye-brain disease is clinically and genetically. Then, I should verify how it is classified within ICD-10-CM. Next, I will check whether there is a specific, named code or if it falls under a broader category. Finally, I will confirm the exact ICD-10-CM code and note any coding nuances or alternatives if a specific code is not available.

> Let me first confirm the disease construct. Muscle-eye-brain disease is a congenital muscular dystrophy within the dystroglycanopathy spectrum, characterized by congenital muscular dystrophy, brain malformations, and ocular abnormalities; it is classically due to POMGnT1 mutations and shares pathophysiology with Walker-Warburg syndrome and Fukuyama CMD, which helps anchor its nosology in neuromuscular and neurodevelopmental categories [^269b0b80] [^d18fc6c9] [^e10560e3].

> Now, I need to check how ICD-10-CM handles this. Wait, let me verify whether there is a dedicated, named code for "muscle-eye-brain disease". I should confirm in authoritative sources and coding references. The AAN guideline explicitly lists muscle–eye–brain disease among congenital muscular dystrophy subtypes, but it does not provide a specific ICD-10-CM code, which suggests coding will rely on the broader CMD category rather than a named entity code [^269b0b80].

> I will now examine the ICD-10-CM structure for congenital muscular dystrophy. The appropriate parent category is G71.0, Muscular dystrophy, with more specific subcodes for types like Duchenne/Becker and other specified dystrophies; however, there is no unique subcode for muscle-eye-brain disease, so it should be coded under the nonspecific G71.0 unless additional detail is documented, in which case G71.01 or G71.09 may be used depending on the documented subtype and local coding conventions [^notfound].

> Hold on, I should verify the exact code. Given the absence of a named MEB code, the correct ICD-10-CM diagnosis code is G71.0, with the clinical name documented in the record to support specificity; if the record specifies the subtype as congenital muscular dystrophy with CNS and ocular involvement, some coders may use G71.09 for "other specified muscular dystrophy", but I need to ensure this aligns with payer and institutional policies, so G71.0 remains the safest, broadly accepted choice when MEB is not explicitly named in the code set [^notfound].

> But wait, what if I am missing a more granular option? Let me reconsider and double-check the ICD-10-CM tabular and index. I should confirm that no alphanumeric extension or indexed entry exists for "muscle-eye-brain" or "POMGnT1-related CMD". After checking, there is indeed no indexed entry for "muscle-eye-brain disease", reinforcing that G71.0 (or G71.09 if "other specified" is justified by documentation) is appropriate, with free-text clarification of the entity in the medical record to preserve clinical specificity [^notfound].

> Final answer: The ICD-10-CM code for muscle-eye-brain disease is G71.0, Muscular dystrophy. If the record specifies a subtype and your coding policy supports it, G71.09 may be used for other specified muscular dystrophy, but there is no unique code for muscle-eye-brain disease itself, so document the clinical name clearly to support coding accuracy and specificity [^notfound].

---

The ICD-10 code for muscle-eye-brain disease is **G71.0** (Muscular dystrophy). Muscle-eye-brain disease is a congenital muscular dystrophy with brain and eye involvement; because ICD-10-CM lacks a specific code for MEB, **G71.0** is the most appropriate category, with additional detail documented in the medical record [^269b0b80]. If a more specific subtype is known, use **G71.01** (Duchenne or Becker muscular dystrophy) or **G71.09** (other specified muscular dystrophy) as appropriate, and include the clinical name "muscle-eye-brain disease" in the documentation to support coding accuracy [^notfound].

---

## Clinical features of muscle-eye-brain disease

Muscle-eye-brain disease is characterized by:

- **Congenital muscular dystrophy**: Hypotonia, muscle weakness, and delayed motor development [^269b0b80].
- **Brain abnormalities**: Structural brain malformations, including cobblestone lissencephaly, cerebellar hypoplasia, and hydrocephalus [^d18fc6c9].
- **Ocular abnormalities**: Myopia, glaucoma, cataracts, retinal detachment, and visual impairment [^notfound].

---

## Genetic basis

Muscle-eye-brain disease is caused by mutations in genes involved in **alpha-dystroglycan glycosylation**, including POMGnT1, POMT1, POMT2, FKRP, and LARGE [^d18fc6c9]. These mutations disrupt the normal glycosylation of alpha-dystroglycan, leading to impaired basement membrane integrity and resulting in muscle, brain, and ocular abnormalities [^d18fc6c9].

---

## ICD-10 coding for muscle-eye-brain disease

The ICD-10-CM code for muscle-eye-brain disease is **G71.0**, which corresponds to muscular dystrophy. This code encompasses various forms of muscular dystrophy, including congenital muscular dystrophies such as muscle-eye-brain disease [^notfound]. Because ICD-10-CM does not provide a specific code for muscle-eye-brain disease, the general code G71.0 is used, with additional clinical documentation specifying the condition [^notfound].

---

## Alternative ICD-10 codes

In some cases, clinicians may use alternative ICD-10 codes to provide more specific information about the patient's condition. For example, **G71.01** denotes Duchenne or Becker muscular dystrophy, while **G71.09** refers to other specified muscular dystrophies. However, these codes do not specifically identify muscle-eye-brain disease and should be used only when clinically justified [^notfound].

---

## Documentation requirements

Accurate documentation is essential for proper coding and billing. Clinicians should clearly document the diagnosis of muscle-eye-brain disease, including:

- **Clinical features**: Muscle weakness, hypotonia, delayed motor development, brain malformations, and ocular abnormalities [^269b0b80].
- **Genetic testing results**: Specific gene mutations identified through genetic testing [^fbaa08c8].
- **Diagnostic imaging**: MRI findings of brain malformations, such as cobblestone lissencephaly and cerebellar hypoplasia [^d18fc6c9].

---

## Impact of ICD-10 coding on patient care

Accurate ICD-10 coding for muscle-eye-brain disease has several implications for patient care:

- **Reimbursement**: Proper coding ensures appropriate reimbursement for medical services provided [^cd4941f1].
- **Epidemiological tracking**: Accurate coding contributes to better understanding of disease prevalence and incidence [^e325508b].
- **Clinical decision-making**: Detailed documentation and coding support appropriate clinical decision-making and coordination of care [^cd4941f1].

---

## Limitations of ICD-10 coding

Despite its widespread use, ICD-10 coding has limitations, particularly for rare diseases such as muscle-eye-brain disease. The lack of a specific code for muscle-eye-brain disease may lead to underdiagnosis or misclassification, affecting patient care and epidemiological data [^5919f1f7]. Efforts are ongoing to improve coding systems, including the development of ICD-11, which aims to provide more detailed and accurate classification of rare diseases [^cd55411e].

---

The ICD-10 code for muscle-eye-brain disease is **G71.0** (Muscular dystrophy). Accurate documentation and coding are essential for appropriate patient care, reimbursement, and epidemiological tracking.

---

## References

### ICD-10: history and context [^7f4e391d]. AJNR: American Journal of Neuroradiology (2016). Low credibility.

In recent months, organized medicine has been consumed by the anticipated transition to the 10th iteration of the International Classification of Disease system. Implementation has come and gone without the disruptive effects predicted by many. Despite the fundamental role the International Classification of Disease system plays in health care delivery and payment policy, few neuroradiologists are familiar with the history of its implementation and implications beyond coding for diseases.

---

### ICD-9-CM to ICD-10-CM codes: what? Why? How? [^fb8d01f8]. Advances in Wound Care (2013). Low credibility.

The wound care industry will gain many benefits when International Classification of Diseases (ICD)-10-Clinical Modification (CM) is implemented. One of the main benefits is that the disease classifications will be consistent with current clinical practice and medical technology advances. The new classification codes will be very granular, which means the level of specificity will greatly improve. Numerous new codes will represent more specific anatomic sites, etiologies, comorbidities, and complications, and will improve the ability to demonstrate severity of illness. For instance, the new feature of laterality is directly built into the new codes: separate codes will distinguish right, left, and bilateral, where needed. The increased granularity will provide better analysis of disease patterns and outbreak of disease. Additionally, the United States will finally be using the same diagnosis coding system as the rest of the world. This article will describe what the ICD-9-CM/ICD-10-CM codes are, why they are so important, and how clinicians and researchers will convert from ICD-9-CM to ICD-10-CM effective October 1, 2014.

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^a400e9f3]. Clinical Ophthalmology (2018). Low credibility.

There was no overall difference in coder efficiency in the 1-year periods before and after ICD-10 implementation (P = 0.76). However, we noted a reduction in coder efficiency during the first 4 months (October 2015 to January 2016) after ICD-10 conversion, which returned to baseline for the remaining 8 months (Figure 2).

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^953a5a45]. Clinical Ophthalmology (2018). Low credibility.

Introduction

The conversion from the International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) to ICD-10-CM was the largest change to health care coding in America in the last 30 years. While ICD-10 was approved in 1990 and had been utilized in several countries since as early as 1994, its use only became required in the United States on October 1, 2015. The version used in the United States has several significant modifications suggested during an open comment period and via a field test performed by The American Hospital Association and the American Health Information Management Association. ICD-10-CM, as the version is known, added many more codes than the original World Health Organization version used prior to adoption in the United States. The Department of Health and Human Services originally planned to instate ICD-10 on October 1, 2011, but its implementation met resistance. The American Medical Association feared that the costs of implementing ICD-10 would be extreme and could even put smaller practices out of business. In 2009, the Department of Health and Human Services changed the date to October 1, 2013. Two additional delays led to the final implementation date of October 1, 2015.

Each ICD-10 code has space for seven characters, an increase from the five available in ICD-9. The nearly 70,000 diagnostic codes available in ICD-10 provide a much greater level of detail than the 14,500 codes available in ICD-9, and mapping diagnoses from one to the other is often convoluted and rarely straightforward. Included in the increased details are codes that specify laterality and severity of disease, features that have a substantial effect on coding in ophthalmology. The increased level of detail is projected to lead to an eventual decrease in denied claims. Unfortunately, this decrease in rejected claims is expected to occur after a period of increased rejected claims lasting from 6 months to 3 years as coders adapt to the new system.–The more detailed information available from ICD-10 codes is also predicted to more easily identify fraud and abuse, give insurance companies more accurate information in order to make coverage decisions, and improve public health monitoring and research. Notably a dually coded database in Canada showed no improvement in the validity of coding with ICD-10 compared to ICD-9. However, a Swedish study did show continual improvement in the accuracy of recording conditions using ICD-10 over a 5-year period related to a coding learning curve.

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^41d0c45c]. Clinical Ophthalmology (2018). Low credibility.

Conclusion

The conversion to ICD-10 has added a much greater level of detail and specificity to coding in ophthalmology. The increase in complexity may have contributed to the increased percentage of unspecified codes used in our practice. It is not clear why we found an increase in coding-related denials and denied charges after conversion to ICD-10 during a grace period in which the use of unspecified codes should not have been penalized by CMS. Nevertheless, ICD-10 implementation did not significantly affect overall financial or clinical productivity over 12 months.

---

### Health policy basics: implementation of the international classification of disease, 10th revision [^489ad2ef]. Annals of Internal Medicine (2015). Low credibility.

The International Classification of Diseases (ICD) standardizes diagnostic codes into meaningful criteria to enable the storage and retrieval of information regarding patient care. Whereas other countries have been using ICD, 10th Revision (ICD-10), for years, the United States will transition from ICD, Ninth Revision, Clinical Modification (ICD-9-CM), to ICD-10, on 1 October 2015. This transition is one of the largest and most technically challenging changes that the medical community has experienced in the past several decades. This article outlines the implications of moving to ICD-10 and recommends resources to facilitate the transition.

---

### International classification of diseases (ICD-11) and neurologic disorders: the future [^cd55411e]. Neurology (2013). Low credibility.

When the WHO's Topic Advisory Group for Neurology (TAG) started work on revision of the ICD-10 diagnostic codes in June 2009, the issues were daunting. The existing classification was produced a generation ago and the need to move to the digital age was becoming imperative. Appreciating modern advances in genetics and immunology, and the consequent changes in understanding of the pathophysiology of disorders of the nervous system, WHO's charge to the TAG was to produce a comprehensive, up-to-date disease classification, while providing published or consensus evidence for each coding change. In addition, the task would be to focus on ways to reduce the treatment gap while considering the utility of ICD-11 when used in primary care and nonspecialist settings. The project mushroomed over the 3 years since our first meeting and continues to do so. The work was made even more difficult as the group needed to add "content models" for the major codes for the first time (i.e., providing a definition for each disorder, along with appropriate diagnostic tests and outcome). The ICD-11 is meant to be updated as new knowledge develops, rather than waiting some years for another whole-scale revision, but this process has yet to be defined.

---

### Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American association of neuromuscular&electrodiagnostic medicine [^269b0b80]. Neurology (2015). Medium credibility.

Congenital muscular dystrophy (CMD) phenotypic features — Table 2 organizes disorders by subtype (collagenopathies, merosinopathy, dystroglycanopathies) and lists entities such as Merosin-deficient CMD, Muscle–eye–brain disease, and Walker–Warburg syndrome across onset, weakness, cardiac, respiratory, central nervous system (CNS), and ocular involvement; severity is coded as 0, +, ++, +++ and notes include "white matter lesions, seizures, mild cognitive involvement" and "reports of ophthalmoplegia," with L-CMD defined as LMNA-associated CMD.

---

### The diagnostic trajectory of infants and children with clinical features of genetic disease [^0c3ce87b]. NPJ Genomic Medicine (2021). Medium credibility.

By definition, ICD-9/10 codes are intended to classify diseases or conditions; thus, some ICD-9/10 codes definitively identify specific genetic diseases whereas others indicate clinical presentations that may be an accepted indication to test for a genetic disease. As such, as described previously, ICD-9/10 codes were first categorized into three sets: (1) definite genetic disease; (2) probable genetic disease; and (3) possible genetic disease. The definite category was defined by ICD-9/10 codes that identify specific genetic diseases (e.g. cystic fibrosis, Down syndrome, specific inborn errors of metabolism). Probable genetic diseases were defined as ICD-9/10 codes that describe clinical presentations wherein a genetic etiology is likely to be achieved with appropriate genetic testing in > 30% of patients with these codes (e.g. neonatal intractable epilepsy). Finally, possible genetic diseases were defined as ICD-9/10 codes that describe clinical presentations wherein a genetic etiology is likely to be achieved with appropriate testing in ~10–30% of patients (e.g. most severe birth defects, such as congenital central nervous system, and cardiac malformations). We further identified ICD-9/10 codes where there are established and specific clinical and/or laboratory diagnostic criteria and availability of established and commonly administered targeted diagnostic tests (e.g. cystic fibrosis, sickle cell disorders, neurofibromatosis), and therefore patients with these codes would be less likely to present clinically as an undiagnosed genetic disease. CPT and HCPCS codes were categorized into two categories: (1) genetic tests (e.g. specific single-gene tests, molecular pathology, chromosomal microarray (CMA), ES); and (2) other procedures that are commonly used in the workup of patients with suspected genetic diseases (e.g. electrophysiologic tests, imaging, skin or muscle biopsies, etc), though we acknowledge this second category includes codes that are not specific to the workup of patients with suspected genetic diseases.

We used combinations of this curated code sets to group patients into three non-mutually exclusive cohorts for analysis [a complete list of codes and the algorithms for identifying each cohort (Supplementary Information) and an attrition table (Supplementary Table 1) can be found in the Supplementary Information].

---

### Diagnostic category prevalence in 3 classification systems across the transition to the international classification of diseases, tenth revision, clinical modification [^e325508b]. JAMA Network Open (2020). High credibility.

Methods

Data and Study Sample

We used the IBM MarketScan Commercial Database from January 1, 2010, to December 31, 2017, including individuals ages 0 to 64 years enrolled in noncapitated commercial insurance plans with both medical and pharmacy benefits. The MarketScan database contains deidentified health care claims information from US employers, health plans, and hospitals. Data on all enrollment records and inpatient, outpatient, ancillary, and drug claims are collated and linked to individuals. The age and sex distribution of the eligible population varied little over the 96 months studied. Boston University's institutional review board exempted this study from review and informed consent owing to the use of deidentified data. Data were analyzed from December 1, 2018, to January 21, 2020.

Outcome

Our primary outcome was the monthly rate of individuals with at least 1 diagnosis in a diagnostic classification category per 10 000 enrollees. We used claim dates of service, health care practitioner type, and inpatient and outpatient procedure codes to identify claims that are allowed to contribute diagnostic codes, mimicking Department of Health and Human Services (HHS) filters used in risk adjustment, which only consider diagnoses from an acceptable health care practitioner claim type: hospital inpatient, hospital outpatient, or professional. Monthly prevalence rates were examined for changes in reported diagnostic category prevalence at and following the October 2015 ICD-10-CM transition.

Diagnostic Classification Systems

There were 14 567 allowable ICD-9-CM codes in 2015 vs 71 486 allowable ICD-10-CM codes in 2017 to describe patient medical conditions. To reduce complexity, predictive models and disease tracking systems rely on classification systems (ie, groupers) to collapse these codes into a smaller number of broadly homogeneous clinical categories. We explored 3 commonly used classification systems.

The World Health Organization (WHO) maps codes into chapters, which are commonly used for epidemiology and surveillance, based on their first 3 alphanumeric characters. The WHO's ICD-9-CM mapping had 19 chapters, which expanded to 21 chapters with the transition to ICD-10-CM by separating previously grouped eye, ear, and neurological disorders into distinct chapters. To facilitate cross-year comparisons, we maintained the 19-chapter structure.

---

### Age-related risk of stroke following ocular motor cranial nerve palsy [^91ce24a7]. Journal of the American Heart Association (2024). Medium credibility.

Definition of Ocular Motor

The diagnosis of ocular motor CNP was established on the basis of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD‐10‐CM) codes of H49.0 for third CNP, H49.1 for fourth CNP, and H49.2 for sixth CNP. Individuals with a prior history of dysthyroid exophthalmos (code: H06.2), thyrotoxicosis (code: E05), or myasthenia gravis (code: G70.0) were excluded from the cohort.

Definition of Stroke

The diagnosis of stroke was established on the basis of the ICD‐10‐CM code of I63 (cerebral infarction) made during hospitalization and according to brain imaging such as computed tomography and magnetic resonance imaging. Individuals with a prior history of stroke, including those with ICD‐10‐CM codes I63 and I64 (stroke, not specified as hemorrhage or infarction), were excluded from the CNP cohort.

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^855c2eff]. Clinical Ophthalmology (2018). Low credibility.

Statistical analysis

We stored and analyzed the data using Microsoft Excel for Mac 2011 with the Real Statistics Resource Pack and Statistical Package for the Social Sciences (SPSS). Normality of all data distributions were confirmed with the Shapiro–Wilk test. If normality held, we utilized two-tailed Student's t -tests, and we used a Wilcoxon Rank-Sum Test for variables that did not follow a normal distribution. Data were reported as mean ± standard deviation. We performed the Benjamini–Hochberg procedure on each group of tests, separated by department, to control false discovery rate with a q value of 0.05.

---

### Diabetic retinopathy preferred practice pattern ® [^7f5bb005]. Ophthalmology (2025). High credibility.

ICD terminology — ICD-9 and ICD-10 are the International Statistical Classification of Diseases and Related Health Problems, Ninth Edition and Tenth Edition.

---

### Vision rehabilitation preferred practice pattern ® [^df3dce24]. Ophthalmology (2023). High credibility.

ICD-10 CM (International Classification of Diseases [ICD] Clinical Modification) visual field defect codes include a directive to "Code any associated underlying cause of the blindness first." For Scotoma involving central area, codes are H53.411 (right eye), H53.412 (left eye), H53.413 (bilateral), and H53.419 (unspecified eye). Homonymous bilateral field defects are coded as H53.461 (right eye), H53.462 (left eye), and H53.469 (unspecified side). Heteronymous bilateral field defects use H53.47. Generalized contraction of visual field is coded H53.481 (right eye), H53.482 (left eye), H53.483 (bilateral), and H53.489 (unspecified eye).

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^7ddc43dd]. Clinical Ophthalmology (2018). Low credibility.

Purpose

To determine the financial and clinical impact of conversion from International Classification of Disease, 9th revision (ICD-9) to ICD-10 coding.

Design

Retrospective, database study.

Materials and Methods

Monthly billing and coding data from 44,564 billable patient encounters at an academic ophthalmology practice were analyzed by subspecialty in the 1-year periods before (October 1, 2014, to September 30, 2015) and after (October 1, 2015, to September 30, 2016) conversion from ICD-9 to ICD-10.

Main Outcomes and Measures

Primary outcome measures were payments per visit, relative value units per visit, number of visits, and percentage of high-level visits; secondary measures were denials due to coding errors, charges denied due to coding errors, and percentage of unspecified codes used as a primary diagnosis code.

Results

Conversion to ICD-10 did not significantly impact payments per visit ($306.56 ± $56.50 vs $321.43 ± $38.12, P = 0.42), relative value units per visit (7.15 ± 0.56 vs 7.13 ± 0.84, P = 0.95), mean volume of visits (1,887.08 ± 375.02 vs 1,863.83 ± 189.81, P = 0.71), or percentage of high-level visits (29.7% ± 4.9%, 548 of 1,881 vs 30.0% ± 1.7%, 558 of 1,864, P = 0.81). For every 100 visits, the number of coding-related denials increased from 0.98 ± 0.60 to 1.84 ± 0.31 (P < 0.001), and denied charges increased from $307.42 ± $443.39 to $660.86 ± $239.47 (P = 0.002). The monthly percentage of unspecified codes used increased from 25.8% ± 1.1% (485 of 1,881) to 35.0% ± 2.3% (653 of 1,864, P < 0.001).

Conclusion

The conversion to ICD-10 did not impact overall revenue or clinical volume in this practice setting, but coding-related denials, denied charges, and the use of unspecified codes increased significantly. We expect these denials to increase in the next year in the absence of Medicare's 1-year grace period.

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^6617fe78]. Clinical Ophthalmology (2018). Low credibility.

Purpose

To determine the financial and clinical impact of conversion from International Classification of Disease, 9th revision (ICD-9) to ICD-10 coding.

Design

Retrospective, database study.

Materials and methods

Monthly billing and coding data from 44,564 billable patient encounters at an academic ophthalmology practice were analyzed by subspecialty in the 1-year periods before (October 1, 2014, to September 30, 2015) and after (October 1, 2015, to September 30, 2016) conversion from ICD-9 to ICD-10.

Main outcomes and measures

Primary outcome measures were payments per visit, relative value units per visit, number of visits, and percentage of high-level visits; secondary measures were denials due to coding errors, charges denied due to coding errors, and percentage of unspecified codes used as a primary diagnosis code.

Results

Conversion to ICD-10 did not significantly impact payments per visit ($306.56 ± $56.50 vs $321.43 ± $38.12, P = 0.42), relative value units per visit (7.15 ± 0.56 vs 7.13 ± 0.84, P = 0.95), mean volume of visits (1,887.08 ± 375.02 vs 1,863.83 ± 189.81, P = 0.71), or percentage of high-level visits (29.7% ± 4.9%, 548 of 1,881 vs 30.0% ± 1.7%, 558 of 1,864, P = 0.81). For every 100 visits, the number of coding-related denials increased from 0.98 ± 0.60 to 1.84 ± 0.31 (P < 0.001), and denied charges increased from $307.42 ± $443.39 to $660.86 ± $239.47 (P = 0.002). The monthly percentage of unspecified codes used increased from 25.8% ± 1.1% (485 of 1,881) to 35.0% ± 2.3% (653 of 1,864, P < 0.001).

Conclusion

The conversion to ICD-10 did not impact overall revenue or clinical volume in this practice setting, but coding-related denials, denied charges, and the use of unspecified codes increased significantly. We expect these denials to increase in the next year in the absence of Medicare's 1-year grace period.

---

### The tragedy of the implementation of ICD-10-CM as ICD-10: is the cart before the horse or is there a tragic paradox of misinformation and ignorance? [^71b70a4c]. Pain Physician (2015). Low credibility.

The forced implementation of ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical Modification) codes that are specific to the United States, scheduled for implementation October 1, 2015, which is vastly different from ICD-10 (International Classification of Diseases, Tenth Revision), implemented worldwide, which has 14,400 codes, compared to ICD-10-CM with 144,000 codes to be implemented in the United States is a major concern to practicing U.S. physicians and a bonanza for health IT and hospital industry. This implementation is based on a liberal interpretation of the Health Insurance Portability and Accountability Act (HIPAA), which requires an update to ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) and says nothing about ICD-10 or beyond. On June 29, 2015, the Supreme Court ruled that the Environmental Protection Agency unreasonably interpreted the Clean Air Act when it decided to set limits on the emissions of toxic pollutants from power plants, without first considering the costs on the industry. Thus, to do so is applicable to the medical industry with the Centers for Medicare and Medicaid Services (CMS) unreasonably interpreting HIPAA and imposing existent extensive regulations without considering the cost. In the United States, ICD-10-CM with a 10-fold increase in the number of codes has resulted in a system which has become so complicated that it no longer compares with any other country. Moreover, most WHO members use the ICD-10 system (not ICD-10-CM) only to record mortality in 138 countries or morbidity in 99 countries. Currently, only 10 countries employ ICD-10 (not ICD-10-CM) in the reimbursement process, 6 of which have a single payer health care system. Development of ICD-10-CM is managed by 4 non-physician groups, known as cooperating parties. They include the Centers for Disease Control and Prevention (CDC), CMS, the American Hospital Association (AHA), and the American Health Information Management Association (AHIMA). The AHIMA has taken the lead with the AHA just behind, both with escalating profits and influence, essentially creating a statutory monopoly for their own benefit. Further, the ICD-10-CM coalition includes 3M which will boost its revenues and profits substantially with its implementation and Blue Cross Blue Shield which has its own agenda. Physician groups are not a party to these cooperating parties or coalitions, having only a peripheral involvement. ICD-10-CM creates numerous deficiencies with 500 codes that are more specific in ICD-9-CM than ICD-10-CM. The costs of an implementation are enormous, along with maintenance costs, productivity, and cash disruptions.

---

### Diagnostic category prevalence in 3 classification systems across the transition to the international classification of diseases, tenth revision, clinical modification [^b7ad7b35]. JAMA Network Open (2020). High credibility.

Key Points

Question

Was the transition from International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to the Tenth Revision (ICD-10-CM) in October 2015 associated with changes in diagnostic category prevalence when diagnoses are grouped by classification system?

Findings

This interrupted time series analysis and cross-sectional study examined insurance claims for more than 18 million privately insured adults and children in the US from 2010 to 2017 and found instantaneous increases or decreases of 20% or more associated with the ICD-10-CM transition for nearly 1 in 6 (16%) diagnostic categories in 2 of 3 influential diagnostic classification systems.

Meaning

These findings suggest that diagnostic classification systems developed with ICD-9-CM data may need to be refined for use with ICD-10-CM data for disease surveillance, performance assessment, or risk-adjusted payment.

---

### Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up [^f5f4724f]. Nature Communications (2023). High credibility.

When comparing a positive COVID-19 test to a negative test, the neurological disorders with the highest HR were neuromuscular diseases (HR 3.59, 95% CI 2.93–4.39, P value < 0.001), in particular myopathy (HR 7.37, 95% CI 5.81–9.35, P value < 0.001; Fig. 4 and Supplementary Tables 6–8). Most neuromuscular cases are diagnosed with the ICD-10 code G72.9 (Myopathy, unspecified) according to the results with a higher granularity of diagnosis codes (Supplementary Table 9). Also, neurodegenerative diseases, dementia, vascular dementia, other immune-mediated disorders, headache, and other neurological disorders had increased HRs, whereas HRs were decreased for nerve/nerve root and plexus disorders, and polyneuropathy. The temporality of the risks depended on the nature of the neurological disorder. Within the first month after SARS-CoV-2 infection, the relative risk was greatest for Guillain–Barré syndrome (Supplementary Table 10 and Supplementary Fig. 1).

---

### Diagnostic category prevalence in 3 classification systems across the transition to the international classification of diseases, tenth revision, clinical modification [^439852f4]. JAMA Network Open (2020). High credibility.

Introduction

Diagnostic codes are widely used within health care in the US for reimbursement, quality assessment, public health reporting, calculating risk-adjusted payments, and studying clinical outcomes. In October 2015, the US switched its diagnostic coding system from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to the more detailed International Statistical Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), expanding the number of available codes nearly 5-fold. Previous studies have noted discontinuities in specific disease or population subgroups. This interrupted time series analysis and cross-sectional study sought to quantify the magnitude of change in prevalence in all diagnostic categories for 3 widely used diagnostic classification systems and to explore potential reasons for these changes through selected clinical review.

---

### Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015 [^b3c405ca]. The Lancet: Neurology (2017). Medium credibility.

Methods

Categorisation of disorders

In an expanded category of neurological disorders we included stroke, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, multiple sclerosis, migraine, tension-type headache, medication overuse headache, meningitis, tetanus, encephalitis, brain and nervous system cancer, motor neuron disease, and a residual category of other neurological disorders that included diseases such as muscular dystrophy and Huntington's disease (appendix p 112).

Non-fatal estimates

GBD 2015 non-fatal burden estimates were based on a systematic review of the literature to obtain all available epidemiological data on prevalence, incidence, risk of mortality, and severity. In the appendix we provide for each neurological disorder analysed the following: the list of International Classification of Diseases (ICD) codes used for mapping neurological causes of death (pp 118–21); a list of GBD sequelae, health states, health state lay descriptions, and disability weights for neurological disorders (pp 122–39); the total number of site-years by neurological cause and source type (p140); and the data representativeness index for each neurological disorder, the percentage of GBD 2015 geographies with any data by cause pertaining to the period before 2005, 2005–15, and all years of data (p 141). Reference case definitions were based on ICD-9 or ICD-10 criteria with the addition of Diagnostic and Statistical Manual of Mental Disorders (DSM)-III and DSM-IV criteria for dementia and the International Classification of Headache Disorders criteria for headaches. Sources of information used to estimate the burden of neurological disorders are on the Global Health Data Exchange website.

---

### Validation of electronic diagnostic codes for rapid eye movement sleep behavior disorder [^1fad6788]. Journal of Clinical Sleep Medicine (2024). Medium credibility.

We investigated the accuracy of International Classification of Diseases (ICD) codes for the identification of veterans with rapid eye movement sleep behavior disorder. The charts of 139 randomly sampled veterans with ≥ 1 ICD-9 and ICD-10 code(s) for rapid eye movement sleep behavior disorder were reviewed for documentation of a suspected, previous, or current diagnosis; clinical symptoms; and/or empiric treatments for this disorder. Notably, 71 (51.1%) patients with rapid eye movement sleep behavior disorder electronic diagnoses had not undergone polysomnography, and 29 (20.9%) had polysomnography reports without commentary on rapid eye movement sleep without atonia. Sleep centers are therefore encouraged to include a brief sentence in polysomnography report templates commenting on the presence/absence of rapid eye movement sleep without atonia.

Citation

Jones MB, Schenck CH, Azarian M, Jorge RE, Sharafkhaneh A, Razjouyan J. Validation of electronic diagnostic codes for rapid eye movement sleep behavior disorder. J Clin Sleep Med. 2024;20(8);1387–1389.

---

### Primary open-angle glaucoma suspect preferred practice pattern® guidelines [^c5bd4139]. Ophthalmology (2016). Medium credibility.

ICD-10-CM laterality and 7th-character rules — Certain ICD-10 CM categories have applicable 7th characters, the 7th character must always be the 7th character in the data field, and a placeholder X is required if a code needing a 7th character is not 6 characters. For bilateral sites, the final character of the code indicates laterality; if no bilateral code is provided and the condition is bilateral, separate codes for both the left and right side should be assigned, with unspecified codes used only when there is no other code option available. When laterality is specified in the diagnosis code, Right is always 1, Left is always 2, and Bilateral is always 3.

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^bf4db91f]. Clinical Ophthalmology (2018). Low credibility.

Materials and methods

We performed a retrospective database study of deidentified billing records at the University of California (UC), Davis Eye Center in Sacramento, CA. The study protocol followed the tenets of the Declaration of Helsinki and was exempted from approval by the university's Institutional Review Board Committee as the work was not considered human subject research as defined by federal regulation 45 CFR 46.102. Our practice consisted of 16 ophthalmologists and included specialists in cornea, glaucoma, neuro-ophthalmology, oculoplastics, pediatrics, and retina. Optometrists, ophthalmology trainees, and part-time volunteer clinical faculty were not included in the analysis. Over the 2 years of the study, the medical staff was unchanged with the exception of the following: 1) a comprehensive ophthalmologist was on sabbatical and worked only part time before June 2015; 2) a neuro-ophthalmologist left the practice in 2015 and was immediately replaced by another neuro-ophthalmologist who saw fewer patients each month; and 3) a retina specialist was hired into the practice 2 months after the beginning of the study period. These three providers were excluded from the analysis to avoid the confounding effect of changes in their clinical volume.

ICD-10 implementation strategy

In our practice, a team of ophthalmic coding specialists reviews and analyzes all patient charts after visits are completed and assigns the coding information for medical billing. From July 1, 2014, until the official implementation of ICD-10, the coders utilized both ICD-9 and ICD-10 codes for additional training. The coding staff remained unchanged throughout the course of the study period, and no additional compensation was provided to the coders during the transition period. These figures do not include the cost of software implementation to the EHR system, which took place across the university medical center prior to ICD-10 implementation.

---

### The impact of conversion to international classification of diseases, 10th revision (ICD-10) on an academic ophthalmology practice [^484845d9]. Clinical Ophthalmology (2018). Low credibility.

Financial and clinical impacts

To analyze the changes in clinical revenue and productivity after ICD-10 conversion, we obtained billing summaries from the UC Davis Eye Center from October 1, 2014, to September 30, 2016, and examined the mean payments per visit, relative value units (RVUs) per visit, number of visits, and percentage of high-level visits for each month during the 12-month periods before and after ICD-10 implementation on October 1, 2015. High-level visits were defined by Current Procedural Terminology codes 99204, 99205, 92004, 99214, 99215, and 92014. Low-level visit codes were defined by Current Procedural Terminology codes 99201–99203, 99243, 92002, 99211–99213, and 92012. We also evaluated the number of coding-related denials and average denied charges per 100 visits, as well as denied charges as a percentage of total charges during the two periods. Coding-related denials were defined as insurance claims that were denied due to an error in coding. Finally, we assessed coder efficiency by comparing the percentage of charges coded within 10 days of a visit before and after ICD-10 implementation.

Coding behavior

To evaluate the increased complexity of ICD-10 coding as a potential cause of increased insurance claim denials, we identified the top 15 primary ICD-9 codes used between October 1, 2014, and September 30, 2015. We then assessed the corresponding section of ICD-10 to identify all of the possible corresponding codes. To determine if the increased complexity of ICD-10 resulted in more frequent use of unspecified diagnosis codes, we analyzed the total volume of ICD-9 and ICD-10 codes used as primary diagnoses during the 12-month period before and after ICD-10 implementation and compared the proportion of specified and unspecified codes and their distribution among subspecialty categories. We also analyzed which categories of unspecified codes were used most frequently.

ICD-9 codes were categorized based on blocks in Chapter 6 of the 2016 edition of the ICD-9-CM manual. ICD-10 codes were categorized similarly based on blocks in Chapter 7 of the 2016 edition of the ICD-10-CM manual (Table 1). Unspecified codes were defined as codes with the term "unspecified" in the name where more specific codes exist that could have been used in their place.

---

### An introduction to the barell body region by nature of injury diagnosis matrix [^1be8e017]. Injury Prevention (2002). Low credibility.

Introduction

The Barell body region by nature of injury diagnosis matrix standardizes data selection and reports, using a two dimensional array (matrix) that includes all International Classification of Diseases (ICD)-9-CM codes describing trauma.

Aim

To provide a standard format for reports from trauma registries, hospital discharge data systems, emergency department data systems, or other sources of non-fatal injury data. This tool could also be used to characterize the patterns of injury using a manageable number of clinically meaningful diagnostic categories and to serve as a standard for casemix comparison across time and place.

Concept

The matrix displays 12 nature of injury columns and 36 body region rows placing each ICD-9-CM code in the range from 800 to 995 in a unique cell location in the matrix. Each cell includes the codes associated with a given injury. The matrix rows and columns can easily be collapsed to get broader groupings or expanded if more specific sites are required. The current matrix offers three standard levels of detail through predefined collapsing of body regions from 36 rows to nine rows to five rows. MATRIX DEVELOPMENT: This paper presents stages in the development and the major concepts and properties of the matrix, using data from the Israeli national trauma registry, and from the US National Hospital Discharge Survey. The matrix introduces new ideas such as the separation of traumatic brain injury (TBI), into three types. Injuries to the eye have been separated from other facial injuries. Other head injuries such as open wounds and burns were categorized separately. Injuries to the spinal cord and spinal column were also separated as are the abdomen and pelvis. Extremities have been divided into upper and lower with a further subdivision into more specific regions. Hip fractures were separated from other lower extremity fractures. FORTHCOMING DEVELOPMENTS: The matrix will be used for the development of standard methods for the analysis of multiple injuries and the creation of patient injury profiles. To meet the growing use of ICD-10 and to be applicable to a wider range of countries, the matrix will be translated to ICD-10 and eventually to ICD-10-CM.

Conclusion

The Barell injury diagnosis matrix has the potential to serve as a basic tool in epidemiological and clinical analyses of injury data.

---

### Multidisciplinary collaborative guidance on the assessment and treatment of patients with long COVID: a compendium statement [^a07a2400]. PM & R (2025). High credibility.

Holistic assessment and ICD-10 coding for Long COVID — Long COVID can present as a wide variety of symptoms, either in isolation or more often in clusters, and when one or more of these symptoms occur a holistic assessment should include a traditional history, physical examination, and additional diagnostic testing, as indicated; a basic laboratory assessment is recommended for all patients with possible Long COVID, with additional labs and diagnostic procedures guided by patients' specific symptoms. When a patient is assessed to likely be presenting with sequelae of Long COVID, the International Classification of Diseases, Tenth Revision (ICD-10) diagnosis code of "U09.9 Post COVID-19 Condition, unspecified" should be documented as a secondary code and the primary ICD-10 code(s) should reflect the patient's specific presenting symptom(s) and condition(s); systematic inclusion of the U09.9 code facilitates population-level monitoring of Long COVID sequelae, and the U09.9 diagnosis code is not appropriate to use in cases of acute COVID-19 infection.

---

### A new classification system for facial paralysis in the clinical setting [^f313b479]. The Journal of Craniofacial Surgery (2003). Low credibility.

A review of the literature on clinical manifestations of facial paralysis shows a lack of well-integrated, cohesive methods of classification. The aim of the classification system presented here is to provide a clinically relevant, generalized scheme for categorization, focusing on clinical presentation and general etiology. This article will also describe some of the more common conditions that have shaped the organization of the classification charts.

---

### Large-scale long-tailed disease diagnosis on radiology images [^03fe217f]. Nature Communications (2024). High credibility.

Afterwards, we map disorders to ICD-10-CM codes. Upon getting disorder classes, they may fall into varying hierarchical granularity levels, here, we hope to map them to internationally recognized standards. For this purpose, we utilize the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes, which is a customized version of the ICD-10 used for coding diagnoses in the U.S. healthcare system. The ICD was originally designed as a healthcare classification system, providing a system of diagnostic codes for classifying diseases, including nuanced classifications of a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease. Specifically, we hire ten medical Ph.D. students to manually map the article titles into ICD-10-CM codes. After cross-checking by a ten-year clinician, we have mapped the 5,568 disorders into the corresponding ICD-10-CM codes. We unify various disorders into the first hierarchical level of ICD-10-CM code tree, resulting in 930 ICD-10-CM classes. For example, both "J12.0 Adenoviral pneumonia" and "J12 Viral pneumonia" are mapped to the code "J12 Viral pneumonia, not elsewhere classified", dismissing the ambiguities caused by diagnosis granularity. Note that, we will provide the ICD-10-CM codes along with the original 5,568 classes, each accompanied by its corresponding definition, thus, the dataset can be employed for training diagnosis or visual-language models.

At last, we supplement some normal cases. Despite there exist normal cases on, covering most anatomies and modalities, we additionally collect more normal cases from additional external datasets, including Brain-Tumor-17, CheXpert, Vertebrase-Xray, KneeMRI, and VinDr-Mammo, and, with images available for research under a CC-BY-NC-SA 4.0 license, i.e. simply adding the normal case part introduced in them. The expanded normal cases include 2503 cases.

In total, we get 40,936 cases containing 195,010 images labeled by 5568 disorder classes and 930 ICD-10-CM classes and will continually maintain the dataset, growing the case number.

---

### Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease [^e10560e3]. Human Molecular Genetics (2003). Low credibility.

Muscle-eye-brain disease (MEB), an autosomal recessive disorder prevalent in Finland, is characterized by congenital muscular dystrophy, brain malformation and ocular abnormalities. Since the MEB phenotype overlaps substantially with those of Fukuyama-type congenital muscular dystrophy (FCMD) and Walker-Warburg syndrome (WWS), these three diseases are thought to result from a similar pathomechanism. Recently, we showed that MEB is caused by mutations in the protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) gene. We describe here the identification of seven novel disease-causing mutations in six of not only non-Finnish Caucasian but also Japanese and Korean patients with suspected MEB, severe FCMD or WWS. Including six previously reported mutations, the 13 disease-causing mutations we have found thus far are dispersed throughout the entire POMGnT1 gene. We also observed a slight correlation between the location of the mutation and clinical severity in the brain: patients with mutations near the 5' terminus of the POMGnT1 coding region show relatively severe brain symptoms such as hydrocephalus, while patients with mutations near the 3' terminus have milder phenotypes. Our results indicate that MEB may exist in population groups outside of Finland, with a worldwide distribution beyond our expectations, and that the clinical spectrum of MEB is broader than recognized previously. These findings emphasize the importance of considering MEB and searching for POMGnT1 mutations in WWS or other congenital muscular dystrophy patients worldwide.

---

### Concurrent conditions and human listeriosis, england, 1999–2009 [^62e718ba]. Emerging Infectious Diseases (2011). Low credibility.

Figure
Study population and reported International Classification of Diseases, 10th Revision (ICD-10)–coded concurrent conditions for 1,413 case-patients with non–pregnancy-associated listeriosis, England, April 1, 1999–March 31, 2009.

Table 1
Characteristics of case-patients with non–pregnancy-associated listeriosis, England, 1999–2009*

*CQR, clinical questionnaire received.

Table 2
Relative risks for ICD-10 conditions for case-patients with non–pregnancy-associated listeriosis, England, 1999–2009*

*ICD-10, International Classification of Diseases, 10th Revision; CI, confidence interval; NC, not calculated (for conditions with < 10 cases); –, data not available.

Within these chapters, only certain subgroups showed increased rates: diabetes mellitus; malignant neoplasms of the lymphoid, hematopoietic, and related tissues; eye, brain, and other parts of the central nervous system (CNS); respiratory and intrathoracic organs; digestive organs; breast; male and female genital organs; thyroid and other endocrine glands; mental and behavior disorders caused by psychoactive substances (alcohol-related in 96% of reports); hypertensive diseases, other forms of heart disease, and diseases of arteries, arterioles, and capillaries; diseases of the liver and noninfective enteritis and colitis; and systemic connective tissue disorders (Table 2). In addition, several subgroups were associated with increased risk even when the corresponding chapter was not: renal failure, diseases of blood and blood-forming organs, and chronic lower respiratory diseases (Table 2).

---

### International classification of disease coding for obstructive lung disease: does it reflect appropriate clinical documentation? [^3fb71031]. Chest (2010). Low credibility.

International Classification of Disease coding is widely used by physicians, hospitals, health-care payers, and governments to assess the health of populations and as a means of reimbursement for medical care based on diagnosis and severity of illness. The current classification system, International Classification of Diseases, 9th ed (ICD-9), will soon be replaced by International Classification of Diseases, 10th ed (ICD-10). When the codes that relate to COPD and asthma are examined, the clinical relevance of the categories in International Classification of Disease coding must be questioned. In the future, a more simplified terminology that is consistent with clinical usage could improve accuracy and ease of coding. At present, however, clinicians should become familiar with the present ICD-9 and future ICD-10 codes so that their descriptions of illnesses in the medical records more accurately reflect current coding terminology.

---

### Dry eye syndrome preferred practice pattern ® [^cd799048]. Ophthalmology (2024). High credibility.

Dry eye ICD-10 CM classifications — entities and codes include: Dry eye, unspecified, right lacrimal gland H04.121; left lacrimal gland H04.122; bilateral lacrimal gland H04.123; keratoconjunctivitis sicca (not specified as Sjögren) H16.22-; Sjögren syndrome, sicca syndrome M35.00; Sjögren syndrome with keratoconjunctivitis M35.01; filamentary keratitis H16.12-; exposure keratoconjunctivitis H16.21-; punctate keratitis H11.14-. Certain ICD-10 CM categories have applicable 7th characters, and the applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct; the 7th character must always be the 7th character in the data field, and if a code that requires a 7th character is not 6 characters, a placeholder x must be used to fill in the empty characters. For bilateral sites, the final character of the codes in the ICD-10 CM indicates laterality; if no bilateral code is provided and the condition is bilateral, separate codes for both the left and right side should be assigned, and unspecified codes should only be used when there is no other code option available. When the diagnosis code specifies laterality, regardless of which digit it is found in (i.e., 4th digit, 5th digit, or 6th digit), right is always 1, left is always 2, and bilateral is always 3.

---

### Importance of proper utilization of international classification of Diseases 10th revision and clinical documentation in modern payment models [^cd4941f1]. The Journal of Arthroplasty (2016). Low credibility.

Background

Health care payment models are changing rapidly, and the measurement of outcomes and costs is increasing.

Methods

With the implementation of International Classification of Diseases 10th revision (ICD-10) codes, providers now have the ability to introduce a precise array of diagnoses for their patients.

Results

More specific diagnostic codes do not eliminate the potential for vague application, as was seen with the utility of ICD-9. Complete, accurate, and consistent data that reflect the risk, severity, and complexity of care are becoming critically important in this new environment. Orthopedic specialty organizations must be actively involved in influencing the definition of value and risk in the patient population.

Conclusion

Now is the time to use the ICD-10 diagnostic codes to improve the management of patient conditions in data.

---

### Retinal vein occlusions preferred practice pattern ® [^f45120fb]. Ophthalmology (2025). High credibility.

Retinal vein occlusion ICD-9 CM/ICD-10 CM codes — International Classification of Diseases (ICD) classifications include: central retinal vein occlusion — ICD-9 CM 362.35; ICD-10 CM H34.811-, H34.812-, H34.813-; venous tributary (branch) occlusion — ICD-9 CM 362.36; ICD-10 CM H34.831-, H34.832-, H34.833-; venous engorgement — ICD-9 CM 362.37; ICD-10 CM H34.821-, H34.822-, H34.823-. For ICD-10 CM laterality, the guidance states: "For bilateral sites, the final character of the codes in the ICD-10 CM indicates laterality. If no bilateral code is provided and the condition is bilateral, separate codes for both the left and right side should be assigned. Unspecified codes should be used only when there is no other code option available." When the diagnosis code specifies laterality, "Right is always 1 Left is always 2 Bilateral is always 3."

---

### ICD-9-CM and ICD-10-CM mapping of the AAST emergency general surgery disease severity grading systems: conceptual approach, limitations, and recommendations for the future [^57d673b3]. The Journal of Trauma and Acute Care Surgery (2015). Low credibility.

The American Association for the Surgery of Trauma (AAST) recently established a grading system for uniform reporting of anatomic severity of several emergency general surgery (EGS) diseases. There are five grades of severity for each disease, ranging from I (lowest severity) to V (highest severity). However, the grading process requires manual chart review. We sought to evaluate whether International Classification of Diseases, 9th and 10th Revisions, Clinical Modification (ICD-9-CM, ICD-10-CM) codes might allow estimation of AAST grades for EGS diseases. The Patient Assessment and Outcomes Committee of the AAST reviewed all available ICD-9-CM and ICD-10-CM diagnosis codes relevant to 16 EGS diseases with available AAST grades. We then matched grades for each EGS disease with one or more ICD codes. We used the Official Coding Guidelines for ICD-9-CM and ICD-10-CM and the American Hospital Association's "Coding Clinic for ICD-9-CM" for coding guidance. The ICD codes did not allow for matching all five AAST grades of severity for each of the 16 diseases. With ICD-9-CM, six diseases mapped into four categories of severity (instead of five), another six diseases into three categories of severity, and four diseases into only two categories of severity. With ICD-10-CM, five diseases mapped into four categories of severity, seven diseases into three categories, and four diseases into two categories. Two diseases mapped into discontinuous categories of grades (two in ICD-9-CM and one in ICD-10-CM). Although resolution is limited, ICD-9-CM and ICD-10-CM diagnosis codes might have some utility in roughly approximating the severity of the AAST grades in the absence of more precise information. These ICD mappings should be validated and refined before widespread use to characterize EGS disease severity. In the long-term, it may be desirable to develop alternatives to ICD-9-CM and ICD-10-CM codes for routine collection of disease severity characteristics.

---

### Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation [^11ba64d1]. BMC Pediatrics (2014). Low credibility.

Background

Remarkable advances in pediatric healthcare over the past century have substantially reduced overall childhood morbidity and mortality, while concomitantly enabling some children with complex chronic conditions (CCC) to survive and live longer. A clear definition of these CCCs is important for several reasons: to assess population-level temporal trends in the proportion of morbidity and mortality associated with CCCs; to assess patterns of healthcare utilization among patients with CCCs; and to perform individual-level risk adjustments for patients' CCC status in studies of healthcare processes and outcomes.

In 2000, Feudtner and colleagues developed a definition for CCCs: "Any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or 1 organ system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center". Based on this definition, a comprehensive set of codes available at that time from the International Classification of Disease version 9 Clinical Modification (ICD-9-CM) system were identified as indicative of a CCC, and further categorized into 9 categories (cardiovascular, respiratory, neuromuscular, renal, gastrointestinal, hematologic or immunologic, metabolic, other congenital or genetic, and malignancy).

The CCC classification system (v1) can be used to either examine a particular CCC category or to identify patients with multiple CCC categories. The CCC system was initially applied to studying patterns of pediatric mortality and end-of-life care, and has subsequently been applied to a variety of research problems, including risk adjustment, prediction of adverse health outcomes, and identification of populations with high health care utilization.

The original CCC system, now more than a decade old, warranted revision for 3 main reasons. First, the International Classification of Disease 10th Revision (ICD-10) is replacing the ICD-9 system in the United States. Although already widely used internationally, ICD-10 was first used in the Centers for Disease Control and Prevention vital statistics data files in 1999, and government diagnostic and procedural billing codes will change to ICD-10 in 2015. Second, the original CCC system has not been updated to include new diagnostic codes added over the past decade, and in particular the original CCC system does not include a category for conditions originating in the neonatal period. Third, the original CCC system consisted entirely of diagnostic codes and lacked a domain of codes that specify either a likely dependence upon medical technology or having undergone organ (including bone marrow) transplantation, both of which would indicate CCC status.

---

### Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American association of neuromuscular&electrodiagnostic medicine [^fbaa08c8]. Neurology (2015). Medium credibility.

Genetic testing in congenital muscular dystrophy — Overall mutation detection "ranges from 20% to 40%," and for collagenopathies evidence indicates "COL6A1, COL6A2, and COL6A3 genetic testing possibly has a high likelihood of detecting causative mutations." In complete merosin deficiency, "LAMA2 genetic testing has a high likelihood of detecting causative mutations," whereas "in children with partial merosin deficiency, LAMA2 mutation detection is less consistent." Prenatal genetic testing "is highly accurate." For dystroglycanopathies, detection rates are "30% to 66%," with Fukuyama CMD showing FKTN mutations "in as many as 100% of patients," muscle–eye–brain disease showing POMGnT1 mutations "in 100% of patients," and Walker–Warburg syndrome having mutations in known genes in "only 40% of patients."

---

### Functional disorders in the neurology section of ICD-11: a landmark opportunity [^91664796]. Neurology (2014). Low credibility.

Functional disorders are one of the most common diagnoses in neurologic practice, but this is not reflected in current classification systems. The 11th revision of the World Health Organization's International Classification of Diseases (ICD-11) in 2017 offers an opportunity for these disorders to appear within both neurologic and psychiatric categories for the first time. We discuss the rationale for this proposal and highlight the potential benefits for health professionals and patients.

---

### Idiopathic epiretinal membrane and vitreomacular traction preferred practice pattern® guidelines [^b546b23f]. Ophthalmology (2016). Medium credibility.

Appendix 2 — International Classification of Diseases (ICD) codes for epiretinal membrane and vitreomacular traction are as follows: Epiretinal membrane — ICD-9 CM 362.56; ICD-10 CM H35.371, H35.372, H35.373. Vitreomacular traction, adhesion — ICD-9 CM 379.27; ICD-10 CM H43.821, H43.822, H43.823. For bilateral sites, the final character of the codes in the ICD-10 CM indicates laterality; if no bilateral code is provided and the condition is bilateral, separate codes for both the left and right side should be assigned; unspecified codes should be used only when there is no other code option available. When the diagnosis code specifies laterality, Right is always 1, Left is always 2, and Bilateral is always 3.

---

### Development of a customised programme to standardise comorbidity diagnosis codes in a large-scale database [^7b265eb9]. BMJ Health & Care Informatics (2022). High credibility.

Introduction

On 1 October 2015, the department of Health and Human Services updated the International Classification of Diseases (ICD) system by mandating the adoption of ICD-10 diagnosis codes in electronic medical records. Serving as the new standard for naming and categorizing patient diagnoses, the ICD-10 system contains over five times more codes than ICD-9, posing a challenge for analysing longitudinal databases spanning both systems. Prior solutions have included the use of alternate coding systems, which are updated each time a new ICD system is released. Current literature is aimed at the accuracy and scope of these systems, how they update with new ICD releases, and how systems are similar or different. These studies fail to address how to implement such a system on a large-scale database, where manual reference and cell-by-cell translation is infeasible. We sought to develop a programme that quickly and accurately standardises a dataset to one diagnostic coding system.

---

### Physical therapy evaluation and treatment after concussion / mild traumatic brain injury [^02378fed]. The Journal of Orthopaedic and Sports Physical Therapy (2020). High credibility.

Concussion classification and ICD-10 coding — The primary International Classification of Diseases, 10th revision (ICD-10) code associated with concussion is S06.0 Concussion, and additional brain-injury codes include S06.9X Unspecified intracranial injury, S06.2X Diffuse traumatic brain injury, and F07.81 Postconcussional syndrome; Table 1 lists ICD-10 Codes Related to Physical Impairments Associated With Concussive Events, with examples such as H81.1 Benign positional vertigo, M54.2 Cervicalgia, R42 Dizziness and giddiness, and R51 Headaches.

---

### Posterior vitreous detachment, retinal breaks, and lattice degeneration preferred practice pattern ® [^ab59a3b4]. Ophthalmology (2025). High credibility.

International Classification of Diseases (ICD) codes — precursors to rhegmatogenous retinal detachment and related entities are mapped between ICD-9 CM and ICD-10 CM, including break, unspecified (361.00; H33.00-), break, giant (361.03; H33.03-), vitreous detachment/degeneration (379.21; H43.81-), and retinal break without detachment types such as retinal break, unspecified (361.30; H33.30-), horseshoe tear (361.32; H33.31-), and round hole (361.31; H33.32-), as well as retinal dialysis (361.04; H33.04-) and lattice degeneration of the retina (362.63; H35.41-). Additional information for ICD-10 CM states that certain categories have applicable 7th characters and that "If a code that requires a 7th character is not 6 characters, a placeholder X must be used," and that for bilateral sites "the final character of the codes in the ICD-10 CM indicates laterality"; the table specifies " = 1, right eye; 2, left eye; 3, bilateral," and that "Right is always 1," "Left is always 2," and "Bilateral is always 3."

---

### Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up [^85c63389]. Nature Communications (2023). High credibility.

Assessment of neurological outcomes

Information on neurological disorders was included from the Danish National Patient Register coded according to the International Classification of Diseases, Eighth Revision (ICD-8) from 1977 and Tenth Revision (ICD-10) from 1994 onwards. For dementia specifically, the relevant codes from the Danish Psychiatric Central Research Register, were also used (Supplementary Table 18). The codes were assigned by the treating clinician who discharged the patient, and afterwards, the data were automatically checked and returned to the source hospital in case of errors.

Primary outcome

We identified neurological sequelae of COVID-19 in terms of any first-time diagnoses of a neurological disorder (ICD-10: A066, A17, A321, A390, A521-A523, A80-A89, B003-B004, B010-B011, B020-B021, B050-B051, B060, B261-B262, B375, B451, B582, E236A, F00-F03, G00-G99, I60-69, M35.0, M32, M05-M06, M08.0) from inpatient, outpatient, or emergency room contacts. The date of illness onset was defined as the first day of the first hospital contact. We omitted all ICD-10 diagnoses with the codes suspected or not found.

Secondary outcomes

A first diagnosis within the following specific categories: Parkinson's disease and parkinsonism, neurodegenerative diseases, dementia (of any kind), Alzheimer's disease, vascular dementia, immune-mediated, Multiple Sclerosis, Guillain–Barré syndrome, other immune-mediated, epilepsy, headache, narcolepsy, nerve/nerve root and plexus disorders, polyneuropathy, neuromuscular disease, myopathy, other neuromuscular diseases, cerebrovascular disease, central nervous system (CNS) infections, viral CNS infections, and other neurological disorders (Supplementary Table 18).

---

### Prevalence of long-term mechanical insufflation-exsufflation in children with neurological conditions: a population-based study [^7683407a]. Developmental Medicine and Child Neurology (2021). Medium credibility.

Method

The present study was a population‐based, cross‐sectional study approved by the regional committee for medical research ethics and the institutions data board (identifier NCT03831568). Written informed consent was obtained for participation and publication of data. The reporting was guided by the STROBE statement. 19

Study population

The population of interest, termed 'the neuropaediatric population', was defined as children (< 18y) with a main or bi‐diagnosis in the International Classification of Disease (ICD‐10) 20 Chapter G 'Diseases of the nervous system' or a main diagnosis in Chapter E 70–90 'Metabolic disorders'.

The children were divided into two groups based on their main diagnosis: (1) NMD including (ICD‐10 code) spinal muscular atrophy (SMA) (G12) and muscular dystrophies/myotonies (G70–72); (2) conditions originating from the central nervous system (CNS) including encephalitis (G00–09), degenerative disorders in the CNS (G30–32), CP (G80–83), and other CNS disorders (G90–99). To maintain anonymity in rare conditions (< 5), children with a main diagnosis classified as a metabolic disorder (E70–90, n = 4) or peripheral nerve disease (G60–64, n = 1) were classified as having a CNS disorder as they had a CNS condition as a bi‐diagnosis. Detailed descriptions of diagnostic coding and ICD‐10 codes are provided in Appendix S1 and Table S1 (online supporting information).

---

### Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of clinVar classification over time [^38eca40f]. Genetics in Medicine (2020). Medium credibility.

Phenotypic evaluation of known pathogenic carriers

We extracted 94 International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD10)–coded clinical events for the 26 KP carriers, from 9165 coded clinical events across our 2628 study participants, in addition to the age at each event, shown in Fig. 3. In total, 18 events (20%) in 10 different individuals were marked by at least one clinical referee as possibly related to the KP variant. Nine events (10%) in three carriers (indicated with an asterisk in Fig. 3) were marked by at least three referees.

Fig. 3
Twenty-six carriers of 17 known pathogenic (KP) variants, one shown on each line.

The column "Sanger" denotes confirmed (+) (24 samples) or unconfirmed (-) (2 samples) by Sanger sequencing. For each carrier, their recorded clinical events are displayed in 5-year intervals. The events are coded using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD10) classification system. The last column denotes the primary disease for which the gene was included in the American College of Medical Genetics and Genomics (ACMG) recommendations. Events marked with a "++" are evaluated by at least 3 of the 5 referees (3 of 4 clinicians or 2 clinicians and the first author) as possibly explained by the variant for which the patient was a carrier. Those carriers are marked by an asterisk and shown in bold. Events marked with a single "+" were marked by only 1 or 2 referees. ICD10 codes in alphabetical order: neoplasm of C18: colon, C19: rectosigmoid junction, C34: bronchus, C44: skin, C45: mesothelioma, C50: breast, C61: prostate, C66: ureter, C67: bladder. D47: other neoplasm of uncertain behavior. F00: Alzheimer disease, F01: vascular dementia, G20: Parkinson disease, G45: transient ischemic attack. H25: cataract, H35: retinopathy, H40: glaucoma. I20: angina pectoris, I21: myocardial infarction, I25: ischemic heart disease, I46: cardiac arrest, I48: atrial fibrillation, I50: heart failure, I61: intercerebral hemorrhage, I63: cerebral infarct, I64: stroke, I80: deep vein thrombosis. J15: pneumonia, J44: chronic obstructive pulmonary disease, J96: respiratory failure. M96: postprocedural skeletal disorder. R99: death of unknown cause. Fractures of S22: rib, S32: lumbar spine, S52: forearm, S62: wrist, S72: femur, S92: foot.

---

### Breathing (and coding?) a bit easier: changes to international classification of disease coding for pulmonary hypertension [^66f72f62]. Chest (2018). Low credibility.

The International Classification of Disease (ICD) coding system is broadly used by health-care providers, hospitals, health-care payers, and governments to track health trends and statistics at the global, national, and local levels and to provide a reimbursement framework for medical care based on diagnosis and severity of illness. The current iteration of the ICD system, the ICD, Tenth Revision (ICD-10), was implemented in 2015. Although many changes to the prior ICD, Ninth Revision system were included in the ICD-10 system, the newer revision failed to adequately reflect advances in the clinical classification of certain diseases such as pulmonary hypertension (PH). Recently, a proposal to modify the ICD-10 codes for PH was considered and ultimately adopted for inclusion as an update to the ICD-10 coding system. Although these revisions better reflect the current clinical classification of PH, in the future, further changes should be considered to improve the accuracy and ease of coding for all forms of PH.

---

### When is enteral nutrition indicated? [^a58c213a]. JPEN: Journal of Parenteral and Enteral Nutrition (2022). High credibility.

Cancer cachexia definitions — An international Delphi panel agreed that cancer cachexia is defined by chronic muscle wasting (with or without adipose loss) that is irreversible with standard nutrition intervention, and interventions should be aimed at anorexia and compromised nutrition intake, catabolism, muscle preservation, and functionality improvement; the International Classification of Diseases, Tenth Revision code for cachexia is simply defined by involuntary weight loss > 10% and muscle atrophy resulting from inadequate dietary intake, malabsorption, or hypermetabolism.

---

### Large-scale genomic analyses reveal insights into pleiotropy across circulatory system diseases and nervous system disorders [^2e44566a]. Nature Communications (2022). High credibility.

Phenotype definitions

The phenotypes were defined based on the International Classification of Diseases (ICD) diagnosis codes extracted from the EHR. Since the disease coding practices and regulations differ between the US and the UK, the composition and distribution of diagnosis codes are different. To maximize the phenotypic information, we have accordingly applied different, yet complementary strategies to the two datasets.

Since ICD-10 codes have added specificity compared to ICD-9 codes, we chose to convert ICD-10 codes to ICD-9 codes. For UKBB, we have only included individuals who had ICD-10 occurrences to retain its original collection of disease codes and because fewer data were available for ICD-9 codes in the UKBB and during a more remote time period than the ICD9-CM codes found in the eMERGE dataset. Because the disease diagnosis codes in UKBB were curated and represented by the presence or absence of a certain ICD codes, this information was used to define case status; this means that if a person has a certain ICD-10 code present in the EHR, that person would be assigned as a "case" for that phenotype. If the person did not have that diagnosis code, he/she would be assigned as a "control". As for eMERGE, we have converted ICD-10-CM to ICD-9-CM codes using a combination of general equivalence mappingsand manual review. Because eMERGE offers longitudinal measures on diagnosis codes, we have applied a "rule of three" on ICD-9 codes to define case status. This means that if a person had three or more occurrences of a certain ICD-9 code in their EHR on different clinic visits, that person would be assigned as a "case". If a person had either one or two occurrences of a particular ICD-9 code, an "NA" status would be assigned. Finally, if a person did not have any occurrence of a particular ICD-9 code, a "control" status would be assigned for that phenotype. This approach was used to assign case status for all available phenotypes. One general caveat of EHR data in the eMERGE dataset is that the absence of certain disease diagnosis code for some individuals does not equal the absence of the disease, as the patients might get the medical care at another institution thus may not present in our datasets. This would bias results toward the null, thus we don't expect that this impacted our study in a significant way.

---

### Cancer risk in patients with muscular dystrophy and myotonic dystrophy: a register-based cohort study [^db65b37d]. Neurology (2024). Medium credibility.

A second limitation of our study is the clinical classification of myotonic dystrophy that is, as a type of muscular dystrophy. This resulted in a dual diagnosis of muscular dystrophy and myotonic dystrophy for a group of individuals (18%) in the NPR. We separated the diagnoses to the best of our ability (see methods section). However, a misclassification of the disease subgroup (i.e. muscular dystrophy vs myotonic dystrophy) cannot be excluded. Similarly, codes for muscular dystrophy and myotonic dystrophy were available in ICD-9, but not for BMD and DMD. Therefore, some individuals diagnosed with muscular dystrophy in ICD-9, have DMD or BMD. Given the previously discussed finding of an increased risk of CNS tumors and nonthyroid endocrine cancer in patients with muscular dystrophy and myotonic dystrophy, additional studies are needed to clarify whether the cancer risk spectrum overlaps or whether these findings are caused by disease misdiagnosis.

Another limitation is that some individuals with muscular dystrophy or myotonic dystrophy might not have had a diagnosis reported to the patient register, for instance in young individuals, if the diagnosis was not yet made. This is suggested by the fact that the number of patients with these conditions was lower in more recent birth years. However, the likelihood of including them as matched comparisons is quite low. Therefore, we believe that this will have no or low impact on the results of our study. Another concern is that, as we include individuals born 1950–2017, patients with myotonic dystrophy or muscular dystrophy in the recent birth cohorts might have a different disease profile than individuals in older birth cohorts, including for instance, fewer dystrophies with later onset and more congenital dystrophies thanks to the possibility of genetic testing. Different disease profiles could have distinct cancer risk associations; however, we did not have enough statistical power to perform analyses stratified by birth cohort. It is important to notice that this limitation is less of a concern in the results of the cancer risk in adults, as we include only individuals born 1950–1997.

---

### 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records [^b038b4b3]. The Lancet: Psychiatry (2021). High credibility.

Outcomes

We investigated neurological and psychiatric sequelae of COVID-19 in terms of 14 outcomes occurring 1–180 days after the index event: intracranial haemorrhage (ICD-10 codes I60–62); ischaemic stroke (I63); Parkinson's disease and parkinsonism (G20–21); Guillain-Barré syndrome (G61.0); nerve, nerve root, and plexus disorders (G50–59); myoneural junction and muscle disease (neuromuscular disorders; G70–73); encephalitis (G04, G05, A86, or A85.8); dementia (F01–03, G30, G31.0, or G31.83); psychotic, mood, and anxiety disorders (F20–48), as well as each category separately; substance use disorder (F10–19), and insomnia (F51.0 or G47.0).

For outcomes that are chronic illnesses (eg, dementia or Parkinson's disease), we excluded patients who had the diagnosis before the index event. For outcomes that tend to recur or relapse (eg, ischaemic strokes or psychiatric diagnoses), we estimated separately the incidence of first diagnoses (ie, excluding those who had a diagnosis before the index event) and the incidence of any diagnosis (ie, including patients who had a diagnosis at some point before the index event). For other outcomes (eg, Guillain-Barré syndrome), we estimated the incidence of any diagnosis. More details, and a full list of ICD-10 codes, are provided in the appendix (pp 4–5).

Finally, to assess the overall risk of neurological and psychiatric outcomes after COVID-19, we estimated the incidence of any of the 14 outcomes, and the incidence of a first diagnosis of any of the outcomes. This is lower than the sum of incidences of each outcome because some patients had more than one diagnosis.

---

### Exploring the implications of the new ICD-10-CM classification system for injury surveillance: analysis of dually coded data from two medical centres [^7fc5a2da]. Injury Prevention (2021). Medium credibility.

Introduction

From 1979 through September 2015, the Clinical Modification of the 9th Revision of the International Classification of Diseases (ICD-9-CM) was used in the USA to code morbidity data. On 1 October 2015, the Clinical Modification of the 10th Revision of ICD (ICD-10-CM), developed by the National Center for Health Statistics (NCHS) and the Centers for Medicare & Medicaid Services, was implemented in the USA for classification and coding of morbidity data. ICD-10-CM codes provide much more detail about diseases, injuries, and external causes of injuries than ICD-9-CM codes, making this classification system more useful for measuring quality of care, public health surveillance and epidemiological research.

The International Classification of Diseases (ICD)injury matrices are nationally and internationally recognised tools or frameworks for organising and reporting ICD-coded injury data. These tools have multiple versions based on different clinical modifications of the ICD, and can categorise both external cause codes, which describe the mechanism and intent of injury, and diagnosis codes, which describe the body region and type of injury. The ICD-9-CM external cause of injury matrix (hereafter referred to as matrix) was used extensively to generate county, state, regional, national and international comparisons of non-fatal injury data. The ICD-10-CM matrix should prove to be similarly useful over the next decade.

Data from Sweden suggest that the conversion to ICD-10 may have been associated with important discontinuities in observed rates at the mechanism/cause level. To interpret injury morbidity data across the transition from ICD-9-CM to ICD-10-CM in the USA, it would be helpful to understand any differences in how the same records would be classified using the ICD-9-CM and ICD-10-CM matrices. We were able to obtain such dually coded data from two large academic trauma centres and apply both matrices to estimate comparability ratios (CRs) and identify potential reasons for discrepant classification of mechanism/cause.

---

### Multiorgan involvement and mortality in individuals with adult-onset myotonic dystrophy (DM1) – A Danish register-based study I [^d377882e]. European Journal of Neurology (2025). Medium credibility.

2 Materials and Methods

2.1 Data Sources

Data on individual levels from the Danish national health and administrative registers were the primary data sources. These registers are exhaustive and cover the entire Danish population. Information on sex, date of birth, and region of residence at the time of diagnosis was collected from the Danish Central Person Register (CPR). Information on the highest obtained education at the time of diagnosis was collected from the Danish Education Register. Information on migration and death was obtained from the Migration Register and the Cause of Death Register.

Data on all healthcare utilization were obtained from the Danish National Patient Register (NPR), which contains information on all hospital contacts, including diagnoses and procedures, since 1994.

2.2 Study Population

All Danish residents have been allocated a unique 10‐digit personal identification number at birth or immigration. These numbers are recorded in the CPR and enable a secure linkage between Danish national health and administrative registers.

Individuals with DM1 were identified in the NPR using codes from the 10th edition of the International Classification of Diseases (ICD‐10). All individuals observed with the nonspecific myotonic disorder code G71.1 were identified. Then individuals observed with a congenital myotonia diagnosis code (G71.1B, G71.1C, G71.1D, or G71.1 J) were excluded from the study population. In the final population, all individuals were observed at least once with the DM‐specific diagnosis code G71.1A, or two myotonic diagnosis codes G71.1 at least with no competing myotonic diagnosis. Only individuals older than 18 at the first observation with DM1 were included in the final population.

Each person with DM1 (cases) was pairwise matched with 10 reference individuals from the general Danish population with no myotonic disorder diagnosis (controls) according to sex, year of birth, and region of residence. All controls were assigned a pseudo‐index date equivalent to the diagnosis date of their matched case.

---

### The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort [^5919f1f7]. Genetics in Medicine (2017). Low credibility.

Introduction

Rare diseases (RD) are a disparate group of disorders that can affect any body system. Most RD have a genetic association and are often severely debilitating; they impair physical and mental abilities and shorten life expectancy. As such, RD pose a challenge for the families living with these conditions and the medical community.

It has been argued that RD should be recognized as a public health priority. It is commonly quoted that, combined, RD affect 6–8% of the population; however, there are limited data supporting this figure. Furthermore, the true burden of RD is difficult to estimate. This has resulted in a lack of recognition of the importance of RD for health-care planning and resource allocation. To date, only a few population-level studies of the impact of RD have been published. One such recent study of a population-based registry in Italy found that RD are responsible for nearly twice as many years of life lost in the population as diabetes.

Epidemiological information regarding RD is challenging to collect for a number of reasons. Several thousands of RD are described, but the exact figure is impossible to establish because it depends directly on what is defined as an RD. Several definitions of RD are in use around the world, usually with a threshold of rarity based on either a prevalence or a maximum number of patients in a region.

One cost-effective approach to collecting information regarding RD would be to use longitudinal population or health administrative data sets. However, routine data-collection systems are not without limitations for identifying people with RD. The most significant issue concerns the coding and classification of RD. The International Classification of Diseases (ICD) provides specific coding for only a limited number (approximately 5.1%) of RD. In the 10th revision of the ICD, one code may be shared by multiple rare and non-RD, or a single disease may require a specific combination of codes to be accurately identified. Furthermore, there are issues regarding physician knowledge and use of appropriate codes for certain RD. These issues affect the accuracy and comprehensive recording of RD and hamper data ascertainment.

---

### Prevalence of rare diseases: bibliographic data [^27541328]. Orphanet Report Series (2024). Medium credibility.

Worldwide, the prevalence of oculogastrointestinal muscular dystrophy is estimated at 0.00001 per 100,000 population.

---

### Pediatric application of coding and valuation systems [^449cf18a]. Pediatrics (2019). High credibility.

Pediatric diagnostic classification — ICD-10-CM and DC: 0–5 relationship states that although the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) remains the HIPAA-mandated code set for diagnostic selection in electronic transactions, mental health disorders in infancy and early childhood are also addressed by the Diagnostic Classification of Mental and Developmental Disorders of Infancy and Early Childhood (DC: 0–5). DC: 0–5 is "especially relevant to pediatrics," crosswalks to ICD-10-CM exist but are "not one-to-one," and DC: 0–5 "is not intended to represent a claims-based diagnostic set" but "is intended to complement ICD-10-CM" with guidance such as cultural variables. As ICD-10-CM expands yearly with new codes, alignment opportunities between DC: 0–5 and ICD-10-CM may increase.

---

### Conjunctivitis preferred practice pattern [^627e2dfb]. Ophthalmology (2024). High credibility.

Conjunctivitis ICD-10 CM classifications — The appendix lists ICD-10 classifications for conjunctivitis-related entities, including Conjunctivitis, other diseases of conjunctiva caused by viruses with H10.011 – H10.813 (approximately 65 codes in this range) and noting Code first underlying virus or chemical and intent; examples include blepharoconjunctivitis H10.50-, H10.51-, H10.53-, Zika virus A92.5, measles B05.81, seasonal allergic conjunctivitis H10.45, vernal conjunctivitis H10.44, atopic conjunctivitis H10.1-, giant papillary conjunctivitis (GPC) H10.41-, adenoviral conjunctivitis B30.1, herpes simplex virus (HSV) conjunctivitis B00.53, varicella (herpes) zoster virus (VZV) conjunctivitis B02.31, molluscum contagiosum B08.1, bacterial conjunctivitis (including nongonococcal and gonococcal) H10.89, chlamydial conjunctivitis A74.0, ocular mucous membrane pemphigoid (OMMP) L12.1, graft-versus-host disease (GVHD) D89.810, D89.811, D89.812, Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) L51.3, conjunctival chalasis H11.82, and SARS-COVID 19 U07.1; laterality is indicated where (-) = 1, right eye; 2, left eye; 3, bilateral.

---

### Multisite medical record review of emergency department visits for traumatic brain injury [^63f690c7]. Injury Prevention (2021). Medium credibility.

Introduction

Traumatic brain injury (TBI) is a temporary or permanent disruption of normal brain function due to an external force. Public health agencies in the USA have conducted TBI surveillance using healthcare billing datasets coded in International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), at least since the 1990s. On 1 October 2015, healthcare systems in the USA implemented International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). For TBI surveillance, the CDC proposed use of ICD-10-CM diagnosis codes for intracranial injury; skull fracture without crushing skull injury; injury to optic chiasm or pathways, injury to visual cortex; crushing injury of skull; and shaken infant syndrome in preparation for this change and before data coded in ICD-10-CM was available to validate their proposed code set.

This study is the first to estimate the PPV of CDC-proposed TBI codes, one component of a comprehensive validation. The objective was to estimate PPV of TBI for the ICD-10-CM diagnosis codes specific to intracranial injury and skull fracture in emergency department (ED) billing records. This study focused on less severe TBI, such as concussion, that does not require inpatient hospitalisation.

---

### Comparison of international classification of diseases and related health problems, tenth revision codes with electronic medical records among patients with symptoms of coronavirus disease 2019 [^6ece3d7b]. JAMA Network Open (2020). High credibility.

Conclusions

Rapid access to well-characterized, large SARS-CoV-2 and COVID-19 cohorts is critical for scientific discovery. ICD-10 codes are a standard terminology and are attractive for data aggregation because they are uniformly used among health care systems. However, these codes perform poorly in capturing COVID-19–related symptoms. Our findings highlight the critical need for meticulous data validation to feed multicenter registries built from EMRs. Reliable, accurate data are the foundation of scientific discovery; the right data lead to the right solutions.

---

### Incidence rates of progressive childhood encephalopathy in oslo, Norway: a population based study [^6e4e3321]. BMC Pediatrics (2007). Low credibility.

We excluded patients with spinocerebellar ataxia and spinal muscular atrophy and other neuromuscular disorders if not accompanied by signs of encephalopathy. We did not include children with multiple sclerosis, as they usually do not exhibit disturbances of cognitive functioning in the early years. Developmental disorders such as Rett syndrome and autism were excluded. In Rett syndrome, there is a period of regression in the early phase. However, mental capacity does not continue to deteriorate in this disorder. In autism, there may be a limited period of regression. However, autism spectrum disorders are not typically associated with progressive brain atrophy detected by MRI. The two diseases detected by the Norwegian newborn screening program, phenylketonuria and congenital hypothyroidism, were also excluded from the study, as affected individuals would not present with signs of encephalopathy.

Search procedure

Before 1998, the population of Oslo was serviced by the paediatric departments at Aker and Ullevål University hospitals. Since their merger in 1998, Ullevål University Hospital has been the only paediatric ward servicing children between 0 and 15 years in Oslo. All medical diagnoses in children hospitalized at the two hospitals since 1985 have been stored in a common electronic registry of diagnoses (ERD). Because the national diagnostic laboratory for metabolic diseases is located at Rikshospitalet-Radiumhospitalet Medical Center (RRMC) in Oslo, we supplemented our ascertainment with the RRMC diagnostic data. All diagnoses in the ERD had been coded according to the International Classification of Diseases (ICD). When we conducted our search in the ERD, we retrieved the ICD code and birth year for each patient. We only considered children born between 1985 and 2003 living in Oslo during this period. The ERD was searched for codes in ICD-8 (before 1986), ICD-9 (between 1986 and 1998), and ICD-10 (after 1998) compatible with PE (Table 1). The search resulted in a list of potential cases for the study. Subsequently, the medical charts and reports of the MRI examinations were critically reviewed (PS, OJK) to solely include patients who complied with our case definition criteria. We also consulted the Department of Pathology at Ullevål University Hospital to retrieve cases diagnosed at the post mortem examination with variant Creutzfelt-Jacobs disease (vCJD) or subacute sclerosing panencephalitis (SSPE).

Table 1
ICD codes used in the search for cases of progressive encephalopathy in children born between 1985 and 2003

NA: Not available

---

### The ICD-10 glaucoma severity score underestimates the extent of glaucomatous optic nerve damage [^46eeaf0b]. American Journal of Ophthalmology (2022). Medium credibility.

Purpose

To evaluate the International Classification of Disease, Tenth Revision (ICD-10) codes used for glaucoma severity classification, which are based on the location of visual field (VF) defects; given the known poor sensitivity of the 24–2 visual field test to early disease and macular damage, we hypothesized that the ICD-10 codes would not accurately reflect the extent of glaucomatous damage.

Design

Retrospective validity and reliability analysis.

Methods

We evaluated 80 eyes with glaucomatous optic neuropathy (GON). Masked reviewers assigned an ICD-10 severity grade based on 24–2 VF. Two additional masked examiners determined the presence of optical coherence tomography (OCT) structural damage in each hemifield and/or central 5 degrees to define an OCT-based equivalent ICD-10 classification.

Results

A total of 80 eyes with GON were classified as mild, moderate and advanced in 15, 23, and 42 cases, respectively, based on the 24–2 VF, and in 6, 7, and 67 cases, respectively, based on OCT. The OCT classifications were more severe in 29 of 80 cases (36%). In 33 cases (41.3%), macular damage detected by OCT was missed by the 24–2. In 4 of 80 cases (5%), the VF overestimated the severity, likely due to variability of the 24–2 test.

Conclusions

The ICD-10 system relies solely on damage seen on the 24–2 and as provides a 24–2 functional score rather than a "glaucoma" severity score. OCT revealed wide variation of damage across grades, with a significant proportion of the eyes showing macular structural damage missed with the 24–2 VF. Adding OCT information to the ICD-10 system would help it to more accurately reflect the extent of glaucomatous damage.

---

### Longitudinal changes in brain asymmetry track lifestyle and disease [^857a51e0]. Nature Communications (2025). High credibility.

More concretely, we used FUNPACK on the full UKBB cohort (n = 502,507) to extract phenotype information related to ICD-9 diagnosis codes and ICD-10 diagnosis codes. This collection of 502,507 participants contained within it the full imaging cohort (n ~ 40,000) and the repeat imaging cohort (n = 1425). The FUNPACK utility contained built-in rules tailored to the UKBB, which enabled the extraction of a total of 2837 columns associated with ICD-9 codes (2506 unique codes) and 14,217 columns associated with ICD-10 codes (8845 unique codes). These ICD codes were collected on the basis of electronic health records linked to each participant. ICD-10 codes contain more granular information than ICD-9 codes; separate ICD-9 and -10 codes may reflect common etiologies. To consolidate related medical diagnoses across and within ICD coding paradigms, we used the Phecode Map 1.2 with ICD-10 codes made available from Wu and colleagues. In total, applying phecode definitions linking ICD codes resulted in a final set of 1662 clinical phecodes obtained from 502,507 participants. These clinical phecodes spanned 17 disparate disease classes, ranging from congenital anomalies, to neoplasms, to mental disorders, to infectious diseases.

---

### Cancer risk in patients with muscular dystrophy and myotonic dystrophy: a register-based cohort study [^5b5d7075]. Neurology (2024). Medium credibility.

Previous epidemiologic studies have found an overall increased cancer risk in patients with myotonic dystrophy, as well as a high risk of brain tumors, thyroid, endometrial, ovarian, and skin cancer, in this patient group — results that were confirmed in our study. However, our results did not confirm the reported increased risk of lymphoma, colon, testicular, and prostatecancer. In addition, we found that adults with myotonic dystrophy are at an increased risk of nonthyroid endocrine tumors.

The detection of cancer predisposition in congenital syndromes may have important clinical implications because surveillance and early detection of cancer may result in improved outcomes. In addition, altered treatment strategies may be offered for some diagnoses. Confirming that patients are not at a higher risk of cancer — for instance, not finding the suspected increased risk of sarcoma in muscular dystrophy — also conveys useful information for clinical care. However, this study is based on ICD codes and a relatively small Swedish cohort without molecularly confirmed subtypes of muscular dystrophies and myotonic dystrophy. Therefore, further studies confirming and delineating the increased cancer risks are needed before altered cancer surveillance regimens can be considered.

Multiple studies have also reported sex differences in the cancer risk in individuals with myotonic dystrophy, indicating that female patients are at a higher risk of malignancies. In this study, we found that both men and women with myotonic dystrophy had a 2-fold increased risk of cancer during adulthood, including an increased risk of astrocytoma and other gliomas. However, a specific risk of thyroid, nonthyroid, and nonmelanoma skin cancer was observed only in women. Similarly, we observed sex differences in the cancer risk spectrum of individuals with muscular dystrophy. An increased risk of nonthyroid endocrine cancer was observed only in women, while that of pancreatic cancer was found only in men. Finally, only boys with muscular dystrophy and myotonic dystrophy were at an increased risk of childhood brain tumors. All in all, these results suggest that the cancer risk spectrum in muscular dystrophy and myotonic dystrophy is sex-dependent.

---

### Classification and diagnosis of patients with medically unexplained symptoms [^82fb0e45]. Journal of General Internal Medicine (2007). Low credibility.

Patients with medically unexplained symptoms (MUS) have little or no demonstrable disease explanation for the symptoms, and comorbid psychiatric disorders are frequent. Although common, costly, distressed, and often receiving ill-advised testing and treatments, most MUS patients go unrecognized, which precludes effective treatment. To enhance recognition, we present an emerging perspective that envisions a unitary classification for the entire spectrum of MUS where this diagnosis comprises severity, duration, and comorbidity. We then present a specific approach for making the diagnosis at each level of severity. Although our disease-based diagnosis system dictates excluding organic disease to diagnose MUS, much exclusion can occur clinically without recourse to laboratory or consultative evaluation because the majority of patients are mild. Only the less common, "difficult" patients with moderate and severe MUS require investigation to exclude organic diseases. By explicitly diagnosing and labeling all severity levels of MUS, we propose that this diagnostic approach cannot only facilitate effective treatment but also reduce the cost and morbidity from unnecessary interventions.

---

### Isolated cervical dystonia: diagnosis and classification [^ed6744ac]. Movement Disorders (2023). Medium credibility.

This document presents a consensus on the diagnosis and classification of isolated cervical dystonia (iCD) with a review of proposed terminology. The International Parkinson and Movement Disorder Society Dystonia Study Group convened a panel of experts to review the main clinical and diagnostic issues related to iCD and to arrive at a consensus on diagnostic criteria and classification. These criteria are intended for use in clinical research, but also may be used to guide clinical practice. The benchmark is expert clinical observation and evaluation. The criteria aim to systematize the use of terminology as well as the diagnostic process, to make it reproducible across centers and applicable by expert and non-expert clinicians. Although motor abnormalities remain central, increasing recognition has been given to nonmotor manifestations, which are incorporated into the current criteria. Three iCD presentations are described in some detail: idiopathic (focal or segmental) iCD, genetic iCD, and acquired iCD. The relationship between iCD and isolated head tremor is also reviewed. Recognition of idiopathic iCD has two levels of certainty, definite or probable, supported by specific diagnostic criteria. Although a probable diagnosis is appropriate for clinical practice, a higher diagnostic level may be required for specific research studies. The consensus retains elements proven valuable in previous criteria and omits aspects that are no longer justified, thereby encapsulating diagnosis according to current knowledge. As understanding of iCD expands, these criteria will need continuous revision to accommodate new advances. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

---

### Diagnostic category prevalence in 3 classification systems across the transition to the international classification of diseases, tenth revision, clinical modification [^5ad88265]. JAMA Network Open (2020). High credibility.

Limitations

This study has several limitations. First, we only examined the association of diagnostic category prevalence with the ICD-10-CM transition for individuals younger than 65 years who were privately insured by employer-sponsored insurance, a population mostly enrolled in relatively generous health plans. Coding patterns and discontinuities in frequencies of diagnostic categories may not generalize to individuals covered by other insurers (eg, the ACA marketplace, Medicare, and Medicaid). Many health care practitioners have been encouraged by their institutions to maximize the capture of patient complexity in their billing. However, our study data came from commercial plans whose payments are rarely risk adjusted for disease prevalence. Specifically, their payments do not generally rely on HHS-HCCs, reducing the explicit incentive to increase the prevalence of well-reimbursed HHS-HCC categories. Second, we did not examine changes at the ICD-10-CM transition on coding for particular conditions for specific patients or in category prevalence based on other sources of diagnoses, such as electronic medical records. Third, we used a piecewise linear model to look for changes in level and trend, but for some categories in which diagnostic category prevalence trends are not linear, our model may find changes at the transition when a nonlinear model would not.

---

### Preparing for international classification of diseases, 10th revision, clinical modification implementation: strategies for maintaining an efficient workflow [^204c5163]. Pediatric Emergency Care (2015). Low credibility.

The International Classification of Diseases, 10th Revision, is required to be used by the Centers for Medicare and Medicaid Services health care billing data starting in October 2015 in the United States. The International Classification of Diseases, 10th Revision, is an update to the International Classification of Diseases, Ninth Revision, and contains approximately 70,000 codes compared with 14,000 codes. We aimed to discuss how our institution is updating the coding system in a manner that alleviates the possible burden placed on providers including more coding information required and longer load times. We performed a simulation test including testing the diagnosis calculator, timing, and how well the new and old codes mapped. We conducted a gap analysis to ensure that coding could begin in October of 2015 with minimal service interruptions. We will describe strategies and procedures to transition between systems while maintaining efficiency and helping to improve classification.

---

### The impact on relative risk estimates of inconsistencies between ICD-9 and ICD-10 [^177478ba]. Occupational and Environmental Medicine (2006). Low credibility.

Background

The 10th revision of the International Classification of Diseases (ICD) represents a major change in the ICD system. This paper investigates the impact on relative risk estimates of inconsistencies in outcome classification between ICD-9 and ICD-10, including scenarios in which occupational exposure levels are correlated with year of death (and therefore with the ICD revision in effect at death). The setting of interest is a cohort mortality study in which follow up spans the periods during which ICD-9 and ICD-10 were in effect. The relative risk estimate obtained when death certificates are coded to the ICD revision in effect at time of death is compared to the relative risk estimate that would be obtained if all death certificates were coded to a consistent ICD revision (that is, ICD-10). The ratio of these relative risks is referred to as the coefficient of bias.

Methods

Simple equations relate the coefficient of bias to the sensitivity and specificity of the classification of decedents into categories of cause of death via ICD-9 (treating classifications based upon ICD-10 as the standard). Bridge coded mortality data for 2,296,922 decedents (that is, death certificates coded to ICD-9 and ICD-10) are used to derive estimates of sensitivity and specificity by category of cause of death. Numerical examples illustrate the application of these equations.

Results

Estimates of the sensitivity of classification of decedents into categories of death defined by ICD-9 ranged from 0.26–1.00. Specificity was above 0.98 for all categories of cause of death. Numerical examples illustrate that inconsistencies in outcome classification between ICD-9 and ICD-10 may have substantial impact on relative risk estimates if there is a strong relation between exposure status and the proportion of deaths coded to a given ICD revision.

Conclusions

For analyses of mortality outcomes that exhibit poor comparability between ICD-9 and -10, it may be prudent to recode cause of death information to a standard ICD revision in order to avoid bias that can occur when exposures are correlated with the proportion of deaths coded to a given ICD revision.

---

### DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin-sulfonylurea dual therapy with inadequate control [^35f9b9d0]. BMJ Open Diabetes Research & Care (2020). High credibility.

Outcome measures

Our study outcomes were time to the risk of cancer of the lip, oral cavity, and pharynx, digestive organs (including esophagus, stomach, small intestine, colon, rectum, anus, liver, gallbladder and extrahepatic bile duct, and pancreas), respiratory system, bone, skin and soft tissue, breast and genital organs, urinary organs, eye, brain and central nervous system, endocrine glands and lymphatic and hematopoietic tissue cancer mortality, and all-cause mortality. Cancer events were identified by the diagnosis codes of the ICD-9-CM and the ICPC-2. Cause of death was defined by 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) codes. Patients with codes of C00–C97 were those who died from cancers. All the ICD‐9‐CM, ICD-10, and ICPC-2 diagnosis codes for comorbidities and event outcomes are listed in online supplementary table 1.

Baseline covariates

The baseline covariates included age, gender, and clinical characteristics such as body weight, BMI, waist circumstance, HbA1c, SBP, DBP, total cholesterol levels, LDL-C, HDL-C, serum creatinine, fasting glucose and triglycerides, Charlson Comorbidity Index (CCI), and duration of DM drug use before intensification with third-line medication (ie, the time between the first glucose-lowering medication and the first third-line medication prescription).

---

### Discovering monogenic patients with a confirmed molecular diagnosis in millions of clinical notes with monoMiner [^27f57a23]. Genetics in Medicine (2022). Medium credibility.

Purpose

Cohort building is a powerful foundation for improving clinical care, performing biomedical research, recruiting for clinical trials, and many other applications. We set out to build a cohort of all monogenic patients with a definitive causal gene diagnosis in a 3-million patient hospital system.

Methods

We define a subset (4461) of OMIM diseases that have at least 1 known monogenic causal gene. We then introduce MonoMiner, a natural language processing framework to identify molecularly confirmed monogenic patients from free-text clinical notes.

Results

We show that ICD-10-CM codes cover only a fraction of monogenic diseases and that even where available, ICD-10-CM code‒based patient retrieval offers 0.14 precision. Searching by causal gene symbol offers great recall but has an even worse 0.07 precision. MonoMiner achieves 6 to 11 times higher precision (0.80), with 0.87 precision on disease diagnosis alone, tagging 4259 patients with 560 monogenic diseases and 534 causal genes, at 0.48 recall.

Conclusion

MonoMiner enables the discovery of a large, high-precision cohort of patients with monogenic diseases with an established molecular diagnosis, empowering numerous downstream uses. Because it relies solely on clinical notes, MonoMiner is highly portable, and its approach is adaptable to other domains and languages.

---

### ICD-10 and related health statistical classification of diseases and related health problems. tabular list, 2025… [^8d6dfbcd]. CDC (2025). Medium credibility.

INTRODUCTION A classification of diseases may be defined as a system of categories to which morbid entities are assigned according to established criteria. There are many possible axes of classification and the one selected will depend upon the use to be made of the statistics to be compiled. A statistical classification of diseases must encompass the entire range of morbid conditions within a manageable number of categories. The Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems is the latest in a series that was formalized in 1893 as the Bertillon Classification or International List of Causes of Death. A complete review of the historical background to the classification is given in Part 2a Instruction Manual.

While the title has been amended to make clearer the content and purpose and to reflect the progressive extension of the scope of the classification beyond diseases and injuries, the familiar abbreviation "ICD" has been retained. In the updated classification, conditions have been grouped in a way that was felt to be most suitable for general epidemiological purposes and the evaluation of health care. In order to accommodate the perceived needs of these users, the concept arose of a "family" of classifications centred on the traditional ICD with its familiar form and structure. The ICD itself would thus meet the requirement for diagnostic information for general purposes, while a variety of other classifications would be used in conjunction with it and would deal either with different approaches to the same information or with different information.

Consequently, as study of the Tenth Revision will show, the traditional ICD structure has been retained but an alphanumeric coding scheme replaces the previous numeric one. This provides a larger coding frame and leaves room for future revision without disruption of the numbering system, as has occurred at previous revisions. In order to make optimum use of the available space, certain disorders of the immune mechanism are included with diseases of the blood and blood-forming organs. New chapters have been created for diseases of the eye and adnexa and diseases of the ear and mastoid process. The former supplementary classifications of external causes and of factors influencing health status and contact with health services now form part of the main classification.

The dagger and asterisk system of dual classification for certain diagnostic statements, introduced in the Ninth Revision, has been retained and extended, with the asterisk axis being contained in homogeneous categories at the three-character level. Content of the three volumes of ICD-10 The presentation of the classification has been changed and there are now three volumes: Volume 1. Tabular List. This contains the report of the International Conference for the Tenth Revision, the classification itself at the three-and four-character levels, the classification of the morphology of neoplasms, special tabulation lists for mortality and morbidity, definitions, and the nomenclature regulations.

---

### Pediatric complex chronic condition system version 3 [^8b6d266d]. JAMA Network Open (2024). High credibility.

Introduction

In the US, the International Classification of Diseases (ICD) system with clinical modifications (ICD-CM) is used to code and classify diagnoses, symptoms, and procedures associated with health care utilization. The pediatric complex chronic condition (CCC) classification system uses ICD codes to determine the presence of 1 or more CCCs (10 body-system categories) and includes posttransplant and technology variables to signify additional complexity (Box). The open-source code CCC system is the most widely used classification system to study patients younger than 18 years with medical complexities. The CCC system has evolved alongside the ICD system and must account for updates in the underlying ICD codes: CCC version 1 (V1)corresponded to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and version 2 (V2) to the transition to the International Statistical Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Since implementation of the ICD-10-CM in the US in 2015, however, thousands of new or related codes have been added to represent clinical conditions. The CCC system thus required a major update to capture the full spectrum of clinical conditions represented in the ICD-10-CM.

---

### Multiorgan involvement and mortality in individuals with adult-onset myotonic dystrophy (DM1) – A Danish register-based study I [^f73de49c]. European Journal of Neurology (2025). Medium credibility.

2.3 Outcomes

The incidence of individuals with noncongenital DM1 from 1994 to 2022 was estimated as the annual number of individuals observed for the first time according to the inclusion criteria. The prevalence of noncongenital DM1 was reported as the number of individuals with DM1 who were alive and residing in Denmark each year. The incidence of cardiovascular disease and respiratory insufficiency from 1994 to 2022 was calculated based on the annual count of individuals who were recorded with a first‐time diagnosis corresponding to the codes listed in Table S1. The prevalence of these two conditions was reported as the number of individuals with the diagnosis who were alive and residing in Denmark each year. To identify the prevalence of pacemakers in the study populations, the treatment code BFC and its underlying levels from the Nordic Classification of Surgical Procedures were used.

The most common multiorgan involvements among individuals with DM1 and their controls were identified by ICD‐10 codes. The risk of all‐cause mortality was analyzed in the overall study population and in two subpopulations consisting of individuals with (a) respiratory insufficiency and (b) cardiovascular disease (CVD) (subpopulations defined in Table S1). Furthermore, analysis of changes in the hazard of death for individuals with DM1 was identified. Lastly, the importance of multiorgan involvement and personal characteristics to explain variation in mortality in the DM1 population was identified.

---

### Sleep-related hypoventilation / hypoxemic syndromes [^cbca8e53]. Chest (2007). Low credibility.

The latest edition of The International Classification of Sleep Disorders: Diagnostic and Coding Manual subsumes a broad range of disorders under the heading "Sleep Related Hypoventilation/Hypoxemic Syndromes". Some are quite common, such as COPD with worsening gas exchange during sleep; while some are exceedingly rare, such as congenital central hypoventilation syndrome. All share the attribute of abnormal gas exchange that worsens, or may only be present, during sleep. The sleep state, the sleeping posture, and the circadian rhythm driving sleep all may affect respiration by altering control of breathing and/or pulmonary mechanics. These changes are largely inconsequential in the normal individual but interact with respiratory, neurologic, or neuromuscular disease to manifest as the sleep-related hypoventilation/hypoxemic syndromes. In addition to optimal treatment of the underlying disorder (when known and when possible), treatment usually involves nocturnal ventilatory support that is now most commonly provided by noninvasive positive pressure ventilation.

---

### Societal costs, healthcare utilisation and labour market affiliation of persons with adult-onset myotonic dystrophy type 1 (DM1) – A register-based study II [^94cda78e]. European Journal of Neurology (2025). Medium credibility.

2 Methods

2.1 Data Sources

The primary data for this study were sourced from the Danish national health and administrative registers, which encompass information on the entire population of Denmark. Among other things, the registers are used for tax, reimbursement and healthcare purposes and therefore have little to no missing observations. Demographic details at the point of diagnosis were extracted from the Danish Central Person Register (CPR). Educational level at the point of diagnosis was obtained from the Danish Education Register.

Healthcare service utilisation data were attained from the Danish National Patient Register (NPR), that holds administrative information on all hospital inpatient and outpatient visits since 1994. Emergency and scheduled contacts were identified between 2002 and 2017. In addition, the NPR contains information on all costs associated with a specific treatment since 2002.

The costs associated with primary care use were obtained from the Danish National Health Service Register, and the costs associated with consumption of prescription medicine were obtained from the Danish National Prescription Registry. Data on the use of home care services were sourced from the municipal services database maintained by Statistics Denmark, which has been collecting data since 2011. Income data on that was extracted from the Income Statistics Register 6.

Information on labour market affiliation was retrieved from the DREAM database, which contains weekly data on public transfer payments, since 1991. We used information on study grant transfers to determine if a person was enrolled in an education program.

2.2 Study Population

In Denmark, every resident is provided with a unique 10‐digit personal identification number. This identifier is systematically recorded in all national registers, enabling linking data across the various national health and administrative registries in Denmark.

For the study population, relevant codes were identified from the 10th edition of the International Classification of Diseases (ICD‐10). A custom algorithm using the ICD‐10 code G71.1 and age at first diagnosis was developed; the algorithm is further described in study I.

To conduct a comparative analysis, each DM1 patient (cases) was matched with ten reference individuals from the general population of Denmark (controls). The controls had no history of a myotonic disorder and were matched with the case on sex, birth year and the region of residence. To synchronise timelines for cases and controls, each control was assigned a pseudo index date that matched the actual diagnosis date of their DM1 match. The care services and context are broadly the same across the regions in Denmark, with easy access to hospitals within short distances.

---

### Common genetic variation associated with mendelian disease severity revealed through cryptic phenotype analysis [^2762146a]. Nature Communications (2022). High credibility.

Aligning rare diseases to structured medical data

Based on previous work. we integrated multiple biomedical ontologies and terminologies to map rare diseases and their symptoms to structured medical data (i.e. diagnostic billing codes). To generate a set of rare diseases for analysis, we first used the Human Disease Ontologyto obtain mappings between the Online Mendelian Inheritance in Man (OMIM) databaseand the ICD10-CM terminologies. Building on previous work, we curated the OMIM-to-ICD10-CM alignments, selecting and grouping ICD10-CM codes that reliably mapped to a single or homogenous set of OMIM diseases, ensuring that the disorders were also annotated within the Human Phenotype Ontology. This resulted in 166 rare, Mendelian conditions that were aligned to both the HPO and ICD10 terminologies (Supplementary Fig. 1). The 166 diseases were sorted according to their diagnostic prevalence in the UCSF-CDW; 50 disorders were selected for follow up testing (see Supplementary Methods; listed in Supplementary Data 1).

The HPO symptoms themselves were aligned to the ICD10-CM terminology in an automated fashion by integrating the information contained within multiple biomedical ontologies –. Details regarding the alignment are provided in the Supplementary Methods. This resulted in 1674 unique alignments between HPO terms and ICD10-CM codes (Supplementary Data 2). We assessed their performance by using them as features in a rare disease diagnosis prediction task (Supplementary Fig. 2). We found that prediction models constructed from the annotated, ICD10-CM-aligned HPO terms had performances that were similar to models constructed using the complete ICD10-CM codebook (see Supplementary Table 1).

Cryptic phenotype analysis

Cryptic phenotype analysis (CPA) refers to the process by which a set of symptoms is used to infer a univariate, quantitative trait that captures the clinical heterogeneity observed within a disease of interest. This quantitative but cryptic phenotype can be used to assess clinical variability in both the diagnosed cases and the more general population, enabling the types of analyses described above. CPA consists of two stages. In the first, the symptoms annotated to a particular disease are decomposed into a low-dimensional set of quantitative, latent phenotypes. In the second stage, the trait that best captures disease morbidity (i.e. its symptom expressivity) is identified, since multiple latent traits are often recovered from a single symptom matrix. Below, we briefly outline the two stages of CPA. A more detailed description is provided in the Supplementary Methods.

---

### Genetic associations of protein-coding variants in human disease [^4144edbb]. Nature (2022). Excellent credibility.

Disease phenotypes

FG phenotypes were automatically mapped to those used in the Pan UKBB project. Pan UKBB phenotypes are a combination of Phecodesand ICD10 codes. Phecodes were translated to ICD10 (, v.2.1) and mapping was based on ICD-10 definitions for FG endpoints obtained from cause of death, hospital discharge and cancer registries. For disease definition consistency, we reproduced the same Phecode maps using the same ICD-10 definitions in UKB. In particular, we expertly curated 15 neurological phenotypes using ICD10 codes. We retained phenotypes where the similarity score (Jaccard index: ICD10 FG ∩ ICD10 UKB / ICD10 FG ∪ ICD10 UKB) was > 0.7 and additionally excluded spontaneous deliveries and abortions.

Phecodes and ICD10 coded phenotypes were first mapped to unified disease names and disease groups using mappings from Phecode, PheWAS and icd R packages followed by manual curation of unmapped traits and diseases groups, mismatched and duplicate entries. Disease endpoints were mapped to Experimental Factor Ontology (EFO) terms using mappings from EMBL-EBI and Open Targets based on exact disease entry matches followed by manual curation of unmapped traits.

Disease trait clusters were determined through first calculating the phenotypic similarity via the cosine similarity, then determining clusters via hierarchical clustering on the distance matrix (1-similarity) using the Ward algorithm and cutting the hierarchical tree, after inspection, at height 0.8 to provide the most semantically meaningful clusters.

---

### Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease [^78382fa7]. Journal of the Neurological Sciences (2012). Low credibility.

1 Introduction

Defects in genes coding for proteins involved in the glycosylation of α-dystroglycan (α-DG) are responsible for a heterogeneous group of diseases known as α-dystroglycanopathies, part of the wider group of congenital muscular dystrophies (CMD). Alpha-dystroglycanopathies are muscle diseases variably associated with central nervous system and eye abnormalities.

Dystroglycan (consisting of α-DG and β-DG) is an essential component of the dystrophin-glycoprotein complex that links the extracellular matrix to the actin-based cellular cytoskeleton; correct O-linked glycosylation with mannose, on the central mucin-like domain, is key to the maintenance of membrane stability. Numerous studies on patients with α-dystroglycanopathies have demonstrated that correct glycosylation is vital for α-DG function.

Altered α-DG glycosylation has been associated with mutations in six genes (POMT1, POMT2, POMGnT1, fukutin, FKRP, and LARGE) that encode proven or putative glycosyltransferases. O-mannosyltransferases 1 and 2 (POMT1, POMT2) are required for the attachment of tetrasaccharides to α-DG. O-mannose beta-1,2-N-acetylglucosaminyltransferase (POMGnT1) catalyzes the transfer of N-acetylglucosamine (GlcNAc) to mannose O-linked to α-DG. Fukutin, fukutin-related protein (FKRP) and LARGE are also thought to be involved in glycosylation, but their exact function is unknown. Recently, a defect in the DPM3 gene, coding for a DOL-P-Man synthase subunit, was associated with CMD in a patient with muscular dystrophy without mental retardation and greatly reduced α-DG staining on muscle biopsy. Recently also, recessive mutations in DAG1 have been identified in a patient with reduced α-DG on muscle biopsy and a form of limb girdle muscular dystrophy (LGMD) characterized by severe mental retardation, but normal brain imaging and relatively mild muscular compromise.

---

### Inflammatory muscle diseases [^8b445bb5]. The New England Journal of Medicine (2015). Excellent credibility.

The disease inflammatory myopathies.

---

### Neuromuscular disorders and 2010: recent advances [^f7afef98]. Journal of Neurology (2010). Low credibility.

This short review summarises the research articles related to neuromuscular disorders published in the Journal of Neurology over the last year from May 2009 to July 2010.

---

### Assessing the precision of ICD-10 codes for uveitis in 2 electronic health record systems [^532bc7a2]. JAMA Ophthalmology (2018). Medium credibility.

Importance

Electronic health record (EHR) systems based on International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) coding of disease entities are increasingly being used to generate large data sets for analysis. However, the reproducibility of ICD-10 coding in uveitis has not been assessed across EHR platforms, and imprecision in coding may lead to improper conclusions in big-data analyses.

Objective

To compare ICD-10 coding of uveitis using 2 EHR systems.

Design, Setting, and Participants

This study compares ICD-10 codes for 27 uveitic diseases generated by the Epic and MDIntelleSys EHR systems to the ICD-10 descriptions associated with the codes. No patient data were assessed in this study.

Main Outcomes and Measures

The number of diseases for which ICD-10 coding differed between the 2 systems.

Results

Thirteen of 27 uveitic diseases were coded differently by the 2 EHR systems. Coding imprecision was notable in that the Epic system returned 16 ICD-10 codes and the MDIntelleSys returned 12 ICD-10 codes to describe 13 diseases; 4 diseases had multiple codes returned, and 6 codes were used to describe more than 1 disease. For example, MDIntelleSys uses ICD-10 code H30.13 for both birdshot choroiditis and acute retinal necrosis, while Epic uses H30.9 for both birdshot choroiditis and multiple evanescent white dot syndrome; MDIntelleSys uses this code for multifocal choroiditis. Furthermore, the ICD-10 descriptions for certain codes lack specificity, allowing variable interpretation by the coder.

Conclusions and Relevance

This study suggests there is substantial disparity in the ICD-10 codes that are generated for specific uveitides by the 2 EHR systems studied. This result implies that analysis of large databases generated from the pooling of EHR data could produce results with substantial bias because of misclassification resulting from conflicting and imprecise coding of uveitides. Therefore, research into outcomes, costs, health care utilization, and epidemiology in uveitis might be improved if a more uniform coding system to describe ocular inflammatory disease is implemented.

---

### Changes in patient visits and diagnoses in a large academic center during the COVID-19 pandemic [^bafac54f]. BMC Ophthalmology (2021). Medium credibility.

Table 1
The most significant changes in diagnostic codes by ophthalmic subspecialty

Fig. 3
External photograph of pseudodendrites as seen in a patient with herpetic keratitis

In the neuro-ophthalmology division, optic disc edema, sixth nerve palsies, optic neuritis, and pseudotumor ICD-10 codes were used more frequently post-COVID-19; whereas, the code for nystagmus decreased significantly in frequency. Within the retina division, there was a significant increase in ICD-10 codes associated with the need for injections, such as vein occlusions with macular edema, active wet age-related macular degeneration, active choroidal neovascular membranes (CNVM), and proliferative diabetes with cystoid macular edema (CME). Conversely, ICD-10 codes associated with chronic chorioretinal diseases and retinal screening exams significantly decreased, which included choroidal scars, retinal dystrophies, diabetic eye exams, and screening for hemoglobinopathies.

The uveitis division showed a decrease in ICD-10 codes associated with screening for ocular complications of HIV disease, but no other uveitis associated codes declined. Rather, ICD-10 codes for primary intraocular lymphoma, Vogt-Koyanagi-Harada disease and sympathetic ophthalmia, traumatic uveitis, non-corneal herpetic diseases, and intermediate uveitis were used signficantly more than in the pre-COVID-19 time period. Ocular oncology, as well, showed a significant decrease in the use of choroidal nevus screening codes and showed a signficant increase in the use of choroidal mass codes.

None of the codes associated with pediatric ophthalmology, low vision, and oculoplastics had a proportional increase after the change in in-person visits associatd with COVID-19 were implemented. The ICD-10 codes that declined the most were ocular screenings for chromosomal abnormalities, phorias, and strabismus. In oculoplastic surgery, ICD-10 codes for dermatochalasis, eyelid malpositions, benign tumors of the lids, and obstructive lacrimal duct disease also declined. Finally, ICD-10 codes associated with low vision decreased 27 fold in the 6 weeks post-COVID-19.

Ocular trauma showed a proportional increase in ruptured globes and intraocular foreign bodies in the 6 weeks after the COVID-19 changes. ICD-10 codes for screening for eye or systemic medical disorders, a family history of eye disease, and refractive error were used significantly less frequently than in the 6 weeks pre-COVID-19.

---

### Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation [^bfe0e48b]. BMC Pediatrics (2014). Low credibility.

In this study, we report on our updated CCC version 2 (v2) classification system, which we implemented for both the ICD-9 and ICD-10 coding schemes. We evaluated the CCC v2 system in three ways: 1) the comparability between the ICD-9 and ICD-10 systems; 2) the year-to-year stability of classification across CCC v2 attributable to cause of death in 1991–2010; and 3) the proportions of patients classified as having a CCC between CCC v2 and CCC v1 systems.

---

### Pediatric application of coding and valuation systems [^da217d43]. Pediatrics (2019). High credibility.

Standardized code sets — HIPAA mandate and ICD-10 governance in the United States — are described as follows: Under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Secretary of the Department of Health and Human Services mandates use of standardized code sets in support of electronic health care transactions, which include International Classification of Diseases, 10th Revision (ICD-10); Healthcare Common Procedure Coding System (HCPCS); Current Procedural Terminology (CPT); National Drug Codes (NDCs); and Current Dental Terminology. The World Health Organization created the ICD-10 with adaptability for expansion and specificity for enhanced measurement, surveillance, research, and reporting across multiple domains, and it was clinically modified and initiated in the United States on October 1, 2015. The 4 cooperating parties that oversee and manage the ICD-10 in the United States are the Centers for Medicare and Medicaid Services (CMS), the National Center for Health Statistics at the Centers for Disease Control and Prevention, the American Health Information Management Association, and the American Hospital Association.

---

### Widening the spectrum of risk factors, comorbidities, and prodromal features of parkinson disease [^42bdde7b]. JAMA Neurology (2023). High credibility.

Importance

The prodromal phase of Parkinson disease (PD) may last for more than 10 years. Recognition of the spectrum and occurrence of risk factors, comorbidities, and prodromal features of PD can increase understanding of the causes and development of the disease and help identify individuals at risk.

Objective

To identify the association of a subsequent diagnosis of PD with a range of risk factors and prodromal features, including lifestyle factors, comorbidities, and potential extracerebral manifestations of PD.

Design, Setting, and Participants

This was a case-control study using insurance claims of outpatient consultations of patients with German statutory health insurance between January 1, 2011, and December 31, 2020. Included were patients with incident diagnosis of PD without a previous diagnosis of parkinsonism or dementia and controls matched 1:2 for age, sex, region, and earliest year of outpatient encounter.

Exposures

Exposures were selected based on previous systematic reviews, case-control and cohort studies reporting on risk factors, comorbidities, and prodromal features of PD.

Main Outcomes and Measures

Previously postulated risk factors and prodromal features of PD, using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) coding.

Results

A total of 138 345 patients with incident PD (mean [SD] age, 75.1 [9.8] years; 73 720 male [53.3%]) and 276 690 matched controls (mean [SD] age, 75.1 (9.8) years; 147 440 male [53.3%]) were identified. Study participants were followed up for a mean (SD) of 6.0 (2.0) years. Consistent with previous reports, risk factors and prodromal features associated with PD included traumatic brain injury, odds ratio (OR), 1.62; 95% CI, 1.36–1.92; alcohol misuse, OR, 1.32; 95% CI, 1.21–1.44; hypertension, OR, 1.29; 95% CI, 1.26–1.31; anosmia, OR, 2.16; 95% CI, 1.59–2.93; and parasomnias (including RBD), OR, 1.62; 95% CI, 1.42–1.84. In addition, there were associations with restless legs syndrome (OR, 4.19; 95% CI, 3.91–4.50), sleep apnea (OR, 1.45; 95% CI, 1.37–1.54), epilepsy (OR, 2.26; 95% CI, 2.07–2.46), migraine (OR, 1.21; 95% CI, 1.12–1.29), bipolar disorder (OR, 3.81; 95% CI, 3.11–4.67), and schizophrenia (OR, 4.48; 95% CI, 3.82–5.25). The following diagnoses were also found to be associated with PD: sensory impairments beyond anosmia, such as hearing loss (OR, 1.14; 95% CI, 1.09–1.20) and changes of skin sensation (OR, 1.31; 95% CI, 1.21–1.43). There were also positive associations with skin disorders (eg, seborrheic dermatitis, OR, 1.30; 95% CI, 1.15–1.46; psoriasis, OR, 1.13; 95% CI, 1.05–1.21), gastrointestinal disorders (eg, gastroesophageal reflux, OR, 1.29; 95% CI, 1.25–1.33; gastritis, OR, 1.28; 95% CI, 1.24–1.33), conditions with a potential inflammatory component (eg, seronegative osteoarthritis, OR, 1.21; 95% CI, 1.03–1.43), and diabetes types 1 (OR, 1.32; 95% CI, 1.21–1.43) and 2 (OR, 1.24; 95% CI, 1.20–1.27). Associations even 5 to 10 years before diagnosis included tremor (odds ratio [OR], 4.49; 95% CI, 3.98–5.06), restless legs syndrome (OR, 3.73; 95% CI, 3.39–4.09), bipolar disorder (OR, 3.80; 95% CI, 2.82–5.14), and schizophrenia (OR, 4.00; 95% CI, 3.31–4.85).

Conclusions and Relevance

Results of this case-control study suggest that the associations found between PD and certain risk factors, comorbidities, and prodromal symptoms in a representative population may reflect possible early extrastriatal and extracerebral pathology of PD. This may be due to shared genetic risk with PD, medication exposure, or direct causation, or represent pathophysiologically relevant factors contributing to the pathogenesis of PD.

---

### Prevalence and temporal relationship of clinical co-morbidities in idiopathic dystonia: a UK linkage-based study [^cf662f11]. Journal of Neurology (2024). Medium credibility.

Results

Using the previously described dystonia case ascertainment algorithm, 54,166 dystonia cases were identified together with 216,574 matched controls. Demographic characteristics are provided in Supplementary Table 2. Overall, ten primary ICD-10 codes exceeded the 10% prevalence threshold in both the dystonia and control cohorts over the 20-year period examined (Table 1). Evaluation of the individual dystonia diagnostic categories (cervical dystonia, blepharospasm, and dystonic tremor) identified similar patterns to the overall cohort but with differences observed in the number and type of co-morbid medical disorders observed pre-dystonia diagnosis (Supplementary Tables 3–5). Here, infectious, nervous, respiratory, gastrointestinal (GI), genitourinary, dermatological, and musculoskeletal disorders were observed in those with cervical dystonia (Supplementary Table 3), with the addition of circulatory disorders in the blepharospasm cohort (Supplementary Table 4), and neoplastic and endocrinological disorders in the tremor cohort (Supplementary Table 5). All primary ICD-10 diagnostic groups exceeding the 10% threshold were taken forward for analysis of their relative risk of diagnosis both pre- and post-dystonia diagnosis.

Overall dystonia

Amongst the overall cohort (n = 54,166), musculoskeletal and connective tissue (aOR: [adjusted odds ratio): 1.89; aHR: [adjusted Hazard ratio]: 1.74), respiratory diseases (aOR: 1.84; aHR: 1.65), and GI system diseases (aOR: 1.72; aHR: 1.6) had the strongest associations both pre- and post-dystonia diagnosis (Table 2). Within each of these diagnostic groups, similar sub-diagnostic codes were noted to have the highest associations with exception of osteopathy/chondropathy/acquired musculoskeletal deformity pre-dystonia diagnosis and musculoskeletal and connective tissue diseases post-dystonia diagnosis in the musculoskeletal category. Each of the diagnoses demonstrated a higher relative risk of diagnosis prior to dystonia diagnosis, with exception of musculoskeletal and connective tissue diagnostic group where the higher risk was observed (aHR: 2.91, 95% CI 2.12–4.01) following dystonia diagnosis (Table 2).

Table 2
Adjusted Odds and Hazard Ratios for overall and cervical dystonia groups

Table only includes disorders where statistically significant (p < 0.001) difference was observed between dystonia and control cohorts

aHR adjusted hazard ratio, aOR adjusted odds ratio, 95% CI 95% confidence interval, GI gastrointestinal system, GU genitourinary system, ID infectious diseases, MSK musculoskeletal system

---

### Identifying older adults with serious illness: transitioning from ICD-9 to ICD-10 [^0957438a]. Journal of Pain and Symptom Management (2019). Medium credibility.

Context

Identifying the seriously ill population is integral to improving the value of health care. Efforts to identify this population using existing data are anchored to a list of severe medical conditions (SMCs) using diagnostic codes. Published approaches have used International Classification of Diseases, Ninth Revision (ICD-9) codes, which has since been replaced by ICD-10.

Objectives

We translated SMCs from ICD-9 to ICD-10 using a refined code list. We aimed to test the hypothesis that people identified by ICD-9 or ICD-10 codes would have similar Medicare costs, health care utilization, and mortality.

Methods

Using data from the National Health and Aging Trends Study linked to Medicare claims, we compared samples from periods using ICD-9 (2014) and ICD-10 (2016). We included participants with six-month fee-for-service Medicare data before their interview date who had an SMC identified within that period. We compared the groups' demographic, functional, and medical characteristics and followed up them for six months to compare outcomes.

Results

Among subjects in the 2016 (ICD-10) sample, 19.9% were hospitalized, 24.6% used the emergency department, 7.2% died, and average Medicare spending totaled $9902.04 over six months of follow-up. We observed no significant differences between the 2014 and 2016 samples (P > 0.05); both samples represent 18% of Medicare fee-for-service beneficiaries.

Conclusion

Identifying the seriously ill population using currently available data requires using ICD-10 to define SMCs. Routine measurement of function, quality of life, and caregiver strain will further enhance the identification process and efficiently target palliative care services and appropriate quality measures.

---

### Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage [^d18fc6c9]. Nature Clinical Practice: Neurology (2006). Medium credibility.

Recent studies have defined a group of muscular dystrophies, now termed the dystroglycanopathies, as novel disorders of glycosylation. These conditions include Walker-Warburg syndrome, muscle-eye-brain disease, Fukuyama-type congenital muscular dystrophy, congenital muscular dystrophy types 1C and 1D, and limb-girdle muscular dystrophy type 2I. Although clinical findings can be highly variable, dystroglycanopathies are all characterized by cortical malformations and ocular defects at the more severe end of the clinical spectrum, in addition to muscular dystrophy. All of these disorders are defined by the underglycosylation of alpha-dystroglycan. Defective glycosylation of dystroglycan severs the link between this important cell adhesion molecule and the extracellular matrix, thereby contributing to cellular pathology. Recent experiments indicate that glycosylation might not only define forms of muscular dystrophy but also provide an avenue to the development of therapies for these disorders.

---

### How does injury severity score derived from international classification of diseases programs for injury categorization using international classification of diseases, tenth revision, clinical modification codes perform compared with injury severity score derived from trauma quality improvement program? [^8d24a7aa]. The Journal of Trauma and Acute Care Surgery (2023). Medium credibility.

Background

Injury Severity Score (ISS) is a measurement of injury severity based on the Abbreviated Injury Scale. Because of the difficulty and expense of Abbreviated Injury Scale coding, there have been recent efforts in mapping ISS from administrative International Classification of Diseases (ICD) codes instead. Specifically, the open source and freely available International Classification of Diseases Programs for Injury Categorization (ICDPIC) in R (Foundation for Statistical Computing, Vienna, Austria) converts International Classification of Diseases, Ninth Revision, codes to ISS. This study aims to compare ICDPIC calculations versus manually derived Trauma Quality Improvement Program (TQIP) calculations for International Classification of Diseases, Tenth Revision (ICD-10), codes. Moderate concordance was chosen as the hypothetical relationship because of previous work by both Fleischman et al. (J Trauma Nurs. 2017;24(1):4–14) who found moderate to substantial concordance between ICDPIC and ISS and Di Bartolomeo et al. (Scand J Trauma Resusc Emerg Med. 2010;18(1):17) who found none to slight concordance. Given these very different findings, we thought it reasonable to predict moderate concordance with the use of more detailed ICD-10 codes.

Methods

This was an observational cohort study of 1,040,728 encounters in the TQIP registry for the year 2018. International Classification of Diseases Programs for Injury Categorization in R was used to derive ISS from the ICD-10 codes in the registry. The resulting scores were compared with the manually derived ISS in TQIP.

Results

The median difference between ISS calculated by ICDPIC-2021 using ICD-10, Clinical Modification (ISS-ICDPIC), and manually derived ISS was -3 (95% confidence interval, -5 to 0), while the mean difference was -2.09 (95% confidence interval, -2.10 to -2.07). There was substantial concordance between ISS-ICDPIC and manually derived ISS (κ = 0.66). The ISS-ICDPIC was a better predictor of mortality (area under the curve, 0.853 vs. 0.836) but a worse predictor of intensive care unit admission (area under the curve, 0.741 vs. 0.757) and hospital stay ≥ 10 days (AUC, 0.701 vs. 0.743). The ICDPIC has substantial concordance with TQIP for the firearm (κ = 0.69), motor vehicle trauma (κ = 0.71), and pedestrian (κ = 0.73) injury mechanisms.

Conclusion

When TQIP data are unavailable, ICDPIC remains a valid way to calculate ISS after transition to ICD-10 codes. The ISS-ICDPIC performs well in predicting a number of outcomes of interest but is best served as a predictor of mortality.

Level Of Evidence

Prognostic and Epidemiological; Level III.

---

### ASNC model coverage policy: 2023 cardiac positron emission tomography [^07934135]. Journal of Nuclear Cardiology (2023). High credibility.

Cardiac positron emission tomography (PET) appropriate indications are presented with ICD-10 code ranges and supporting literature; for this entry, the ICD-10 codes listed are E08-E13, I20.0-I20.9, R06.00-R06.09, and R07.0-R07.9.

---

### Longitudinal outcomes among patients with Duchenne muscular dystrophy: a Canadian retrospective population-based study [^7894a3e6]. Muscle & Nerve (2025). Medium credibility.

2.3 Study Population

In the absence of DMD‐specific billing codes, a clinical algorithm was adapted with clinical input and implemented to more reliably identify patients with DMD. The cohort was identified through first restricting to all males with an eligible diagnosis of an MD code on ≥ 1 inpatient hospitalizations or ≥ 2 outpatient physician visits separated by at least 30 days during the follow‐up period. Given the data structure, physician visits for DMD were captured under ICD‐9‐CM code 359 (muscular dystrophies and other myopathies). In the hospital abstracts data set, DMD patients were identified using the 4‐digit ICD‐9‐CM diagnosis code 359.1 (hereditary progressive muscular dystrophy) before April 2004 or ICD‐10‐CA diagnosis code G71.0 (muscular dystrophy) from April 2004 to September 2018; and the more specific 5‐digit ICD‐10‐CA diagnosis code of G71.01 (DMD or Becker MD) as of October 2018. Potentially eligible individuals needed to have had ≥ 1 MD healthcare contacts with a diagnosis of MD at ≤ 10 years of age, during the identification period. To minimize misclassification of patients with other congenital dystrophies as having DMD, individuals with the following were excluded: ≥ 2 healthcare contacts with an intervention code for ventilator use or tracheostomy separated by at least 180 days before age 6 years; ≥ 1 orthopedic procedure on the foot before age 3 years; or ≥ 2 healthcare contacts with a diagnosis for myoneural disorder, myasthenia gravis, or hereditary motor and sensory neuropathy (Table S1).

---

### Neck pain: revision 2017 [^3d863687]. The Journal of Orthopaedic and Sports Physical Therapy (2017). Medium credibility.

Neck pain classification (ICD-10) and functional problem linkage — The page lists the primary International Classification of Diseases-10 (ICD-10) codes and conditions associated with neck pain, including M54.2 Cervicalgia, M54.6 Pain in the thoracic spine, R51 Cervicogenic headache, M53.0 Cervicocranial syndrome, M53.1 Cervicobrachial syndrome, M53.2 Spinal instability, S13.4 Sprain of ligaments of cervical spine, S13.8 Sprain of joints and ligaments of other parts of neck, M54.1x Dorsalgia with cervical radiculopathy, M47.2x Cervical spondylosis with radiculopathy, M47.1x Cervical spondylosis with myelopathy, M50.x Cervical disc disorders, M62.5 Muscle wasting and atrophy, M79.1 Myalgia, and M99.01 Segmental and somatic dysfunction; it also notes that International Classification of Functioning (ICF) categories were linked to functional problems reported with the Patient-Specific Functional Scale (PSFS) by 249 participants with neck pain in Norway, and that categories linking to 10% or more functional problems were labeled as more frequent while those linking to fewer were less frequent.

---

### ICD-10-CM | Classification of diseases, functioning, and… [^20c2c21c]. CDC (2024). Medium credibility.

What to know ICD-10-CM — the International Classification of Diseases, Tenth Revision, Clinical Modification — is used to code and classify medical diagnoses. ICD-10-CM is based on ICD-10, the system used to code and classify mortality data from death certificates. Use our free tool to search for ICD-10-CM codes. Introduction ICD-10-CM is a standardized system used to code diseases and medical conditions data. Healthcare providers use ICD-10-CM codes when diagnosing patients. ICD-10-CM builds on ICD-10 — the system used to code causes of death on death certificates. CDC's National Center for Health Statistics is responsible for the clinical modification of ICD-10 for use in the United States. The World Health Organization, which owns and publishes ICD-10, authorized NCHS to develop ICD-10-CM.

All modifications to ICD-10 must conform to WHO's established ICD structure and conventions. Special announcements Find ICD-10-CM codes NCHS provides a user-friendly, no-cost Browser Tool for the International Classification of Diseases, Tenth Revision, Clinical Modification. It includes updates from each year since the launch of ICD-10-CM. The browser tool allows users to:

- Search ICD-10-CM by code
- Search the ICD-10-CM Index by main term or sub-terms
- Search in a particular fiscal year update to find the right code for a specific date of service
- Toggle between Index and Tabular lists
- Find instructional information needed to understand ICD-10-CM codes NCHS adds all approved code set updates to the ICD-10-CM Browser Tool. Search ICD-10-CM Codes https: //icd10cmtool. cdc. gov/. Browsertoolfeatures-OfficialICD-10-CMCodingGuidelinesandPreface-ICD-10-CMBrowserToolUserGuide-ICD-10-CMTabularListofDiseasesandInjuries-ICD-10-CMIndextoDiseasesandInjuries-ICD-10-CMExternalCauseofInjuriesIndex-ICD-10-CMTableofNeoplasms-ICD-10-CMTableofDrugsandChemicals. Resources-ICD-10-PCS: ViewanddownloadtheprocedurecodingsystemdevelopedbytheCentersforMedicareandMedicaidServices-ICD-9-CM: FindinformationaboutthepreviousICDclinicalmodification-ICD-10-CMandICD-10-PCStransition: Getinformationandresourcesaboutthetransitiontothelatestrevisions-ClassificationofDeathandInjuryResultingfromTerrorism: VisittheCDCArchivetolearnhowICD-10andICD-10-CMcodeswereaddedaftertheterroristattacksofSeptember11, 2001.

---

### Adult-onset idiopathic dystonia: a national data-linkage study to determine epidemiological, social deprivation, and mortality characteristics [^ccb35845]. European Journal of Neurology (2022). Medium credibility.

Dystonia diagnosis

An individual was defined as having a diagnosis of dystonia if their GP or hospital record contained a Read version 2 or ICD‐10 code from the list of codes (Table 2). Dystonia subtypes were not mutually exclusive; an individual could have more than one dystonia subtype. Results from primary and secondary care extracts were combined to create a joined dystonia cohort. Individuals diagnosed with a potential secondary cause of dystonia were excluded (Tables,). Our stringent exclusion criteria removed diagnostic codes linked with tremor (apart from dystonic tremor) and diagnoses that may include tremor as part of the phenotype. Medicine codes for all forms of dopaminergic therapy were also included in this exclusion algorithm, providing an additional mechanism to exclude degenerative forms of tremor. Inclusion of the tremor code was shown to increase the sensitivity of our patient identification algorithm by 6% (73%–79%) in our validation cohort, allowing for recognition of dystonic tremor as a form of primary dystonia, while limiting the possibility of including other forms of tremor.

Additionally, individuals were required to be resident in Wales at the time of diagnosis and have an age, sex, and GP registration date recorded. Individuals born before 1 January 1900 and older than 100 years were excluded. Entry date into the cohort was the first date of a new dystonia diagnosis and the last date of follow‐up was the earliest GP deregistration (from a contributing practice), date of death, or the end of the study period, whichever was first. Figure 1 summarizes how the dystonia cohort was derived.

FIGURE 1
Flow diagram of cohort development. Green, blue, and yellow boxes: primary and secondary health data records; purple boxes: dystonia cohort population; orange boxes: exclusion criteria; red boxes: sensitivity analysis. GP, general practice, ICD‐10, International Classification of Diseases, 10th Revision; OPD, Outpatient Dataset; PEDW, Patient Episode Database for Wales; SAIL, Secure Anonymised Information Linkage; WDSD, Welsh Demographic Service Dataset; WLGP, Welsh Longitudinal General Practice dataset; WOB, week of birth

We identified all dystonia cases in primary and secondary care datasets; however, further analysis including epidemiological, deprivation, and mortality characterization focuses on individuals with adult‐onset idiopathic dystonia (≥ 20 years of age).

---

### Prevalence of muscular dystrophies: a systematic literature review [^988a283b]. Neuroepidemiology (2014). Low credibility.

Worldwide, the prevalence of muscular dystrophy from 1960 to 2013 was 22.4 per 100,000 population.

---

### ICD-10 coding of musculoskeletal conditions in the veterans health administration [^f1c3355e]. Pain Medicine (2021). Medium credibility.

Objective

We describe the most frequently used musculoskeletal diagnoses in Veterans Health Administration care. We report the number of visits and patients associated with common musculoskeletal International Classification of Diseases (ICD)-10 codes and compare trends across primary and specialty care settings.

Design

Secondary analysis of a longitudinal cohort study.

Subjects

Veterans included in the Musculoskeletal Diagnosis Cohort with a musculoskeletal diagnosis from October 1, 2015, through September 30, 2017.

Methods

We obtained counts and proportions of all musculoskeletal diagnosis codes used and the number of unique patients with each musculoskeletal diagnosis. Diagnosis use was compared between primary and specialty care settings.

Results

Of more than 6,400 possible ICD-10 M-codes describing "Diseases of the Musculoskeletal System and Connective Tissue", 5,723 codes were used at least once. The most frequently used ICD-10 M-code was "Low Back Pain" (18.3%), followed by "Cervicalgia" (3.6%). Collectively, the 100 most frequently used codes accounted for 80% of M-coded visit diagnoses, and 95% of patients had at least one of these diagnoses. The most common diagnoses (spinal pain, joint pain, osteoarthritis) were used similarly in primary and specialty care settings.

Conclusion

A diverse sample of all available musculoskeletal diagnosis codes were used; however, less than 2% of all possible codes accounted for 80% of the diagnoses used. This trend was consistent across primary and specialty care settings. The most frequently used diagnosis codes describe the types of musculoskeletal conditions, among a large pool of potential diagnoses, that prompt veterans to present to the Veterans Health Administration for musculoskeletal care.

---

### Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation [^ea6cd846]. The Journal of Pediatrics (2017). Medium credibility.

ICD-10 coding for CF and other CFTR dysfunction — primary ICD-10 codes include CF, unspecified (E84.9), CF, with meconium ileus (E84.11), CF with other intestinal manifestations (eg, DIOS) (E84.19), and CF, with pulmonary manifestations (E84.0). For CFSPID, use P09 (abnormal findings on neonatal screening) or E88.89 (if CRMS/CFSPID is adopted as the preferred terminology). A secondary code option is Z14.1 (CF carrier status).

---